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CHAPTER 1
 
INTRODUCTION 
Selenium is a unique element. It was initially thought of as a toxicant, but is now 
recognized as a nutrient, and it was also originally classed as a carcinogen, but is now 
known to be an anticarcinogen. The first interest in biological research on selenium began 
in 1933 with the quest for a toxic principle in plants which grew in the midwest of United 
States. Animals consuming those plants exhibited a variety of injuries to the nervous 
system, the liver and the integument. Studies showed (Franke, 1934) that the toxicity was 
caused by selenium, which had been taken up and incorporated into amino acids by plants 
because of high concentrations in the soil.  Selenium toxicity can be manifested in 
different ways (Olson, 1986). Alkali disease was characterized by loss of hair and hoof 
tissue in cattle and horses consuming a moderately toxic dose over a considerable time, 
while a large dose consumed all at once resulted in central nervous system damage (called 
blind staggers ) and often death. 
Selenium toxicity in humans is rare. An effect of substantially high selenium levels 
on human health was found in China,  Enshi county of Hubei province, due to 
consumption of locally grown vegetables. This caused a high prevalence of selenosis 
which is characterized by hair and nail loss, dermatitis, nausea, garlic odor in the breath, 
fatigue, irritability and hyperreflexia (Yang et al, 1983). 2 
The turning point on the perception of selenium occurred in 1957 with the 
discovery that selenium would prevent dietary liver necrosis in rats (Schwarz and Foltz, 
1957). This was a significant discovery because the only feature about this element until 
this time was thought to be its toxicity. Interestingly, this same year, the properties of a 
newly discovered enzyme, glutathione peroxidase, was reported (Mills, 1957), which was 
found to protect erythrocytes against oxidative hemolysis. However, it took over fifteen 
years before selenium and this enzyme was found to have something in common, namely 
glutathione peroxidase is a selenoenzyme (Rotruck et al, 1973). 
Selenium is an essential dietary nutrient for many mammalian species including 
humans (Oldfield, 1987). It was definitely established to be essential for animals when it 
was shown to be an essential component of glutathione peroxidase, a widely dispersed 
mammalian enzyme (Rotruck et  al,  1973; Smith et  al,  1974). Selenium in this 
selenoprotein is present as  selenocysteine (Forstrom  et al,  1978).  Glutathione 
peroxidase activity is now recognized as one of the best indicators of selenium status 
because it can be used as an index for the determination of selenium requirements. In 
addition to this first selenoenzyme (later named cellular glutathione peroxidase) 
discovered, other selenoenzymes or selenoproteins have been identified, as discussed 
later. 
In humans, severe dietary selenium deprivation in discrete regions of China is 
associated with an endemic juvenile cardiomyopathy called Keshan disease (Chen et al, 
1980). Selenium deficiency also can contribute to the problems associated with cretinism 
(Goyens et al, 1987). 3 
One of the most dramatic and controversial aspects of  selenium are its 
relationships to different types of cancer. Selenium was suggested as a carcinogen in 
animal studies at the U.S. Food and Drug Administration Laboratories in 1942 (Nelson 
et al, 1943). Unfortunately, selenium continues to be listed in some texts as a carcinogen. 
Studies on the carcinogenic effects of selenium compounds were evaluated  by IARC 
(International Agency for Research in Cancer, 1975): The IARC report in 1975 concluded 
that available animal data did not indicate that selenium was tumorigenic, and the available 
human data provided no suggestion that selenium was carcinogenic. More recently, a 
growing body of evidence has accumulated to indicate that selenium can be an effective 
anticarcinogen at levels well above the dietary requirements (Combs et al, 1986; Ip, 1989; 
Ip et al, 1992). Furthermore, human supplementation studies with selenium suggests a 
reduction in the incidence of certain cancers in a study with a Chinese population (Blot 
et al, 1993) and in a report just published with American subjects (Clark et al, 1996). 
Another distinctly unique aspect of selenium is its role in the counteraction of the 
toxicity of certain metals (Whanger, 1985; Whanger, 1992). Solid evidence exists for 
protective effects of selenium against toxicity of cadmium (Kar et al, 1960),  lead 
(Cerklewski and Forbes, 1976), mercury (Ganther and Sunde, 1974), silver (Diplock, 
1976), and thallium (Whanger, 1981). These effects may occur through the promotion 
of binding to high molecular weight proteins and through the formation of insoluble heavy 
metal selenides. 4 
SELENIUM TOXICITY ASSESSMENT 
A number of factors must be considered in the toxicity assessment of selenium. 
First, selenium is an essential nutrient whose range of exposure levels must be considered 
from deficient levels to adverse toxic effects (Mertz, 1983). Secondly,  selenium can 
interact with other compounds to increase or decrease their toxicity.  For example, 
selenium deficiency causes animals to be more sensitive to the toxic effects  of certain 
chemicals such as paraquat or diquat (Burk et al, 1980) and selenium protects animals 
against the toxicity of metals such cadmium, mercury and thallium (Whanger, 1981). 
Finally, there is  increased evidence that levels of selenium at above the dietary 
requirement may prevent certain cancers ( Thompson, 1984; Clark et al,  1996). If high 
levels of selenium are given to subjects for cancer prevention, a greater understanding of 
the mechanism of selenium toxicity is needed, and a biological marker  is needed to 
indicate impending problems before selenium toxicity appears. 
Selenium toxicity in animals 
Although chronic toxicity in horses was first observed in the 1860s in Nebraska, 
selenium was not recognized as the causative agent until the 1930s (Franke,1934; Tully 
and Franke, 1935). Three types of selenium toxicity have been characterized based on 
livestock and laboratory animal studies (Olson, 1986). The first is acutetoxicity, in which 
the animals consume a sufficient quantity of highly selenoferous plants to cause severe 
symptoms with death often following within a few hours.  Second, chronic selenium 
toxicity of the blind staggers type, in which exposure of animal to a moderate  toxic dose 5 
over a considerable period of time is marked by central nervous system  damage and 
respiratory distress. The blood selenium levels are often as high as 4 ppm. Third, chronic 
toxicity of the alkali disease type, in which the animals exposed to a moderate dose of 
selenium over a long time is marked by loss of hair and hooves. The blood selenium levels 
typically range from 2 to 3 ppm. 
Selenium toxicity in humans 
Although rare in humans, both acute and chronic cases of selenosis have been 
reported. The acute cases have usually been accidental such as selenium supplementation 
tablets which contained up to 27 mg selenium/tablet due to a manufacturing error 
(Helzlsouer et al, 1985). Documented cases of acute selenium toxicity in humans have 
mostly resulted from occupational exposure of workers in copper smelting or selenium 
rectifier plants (Combs et al, 1986). A convincing and well substantiated occurrence of 
chronic selenium toxicity in humans was presented by Yang et al (1983). In Enshi County 
of Hubei province, an endemic disease of especially high prevalence during 1961-1964 
was diagnosed as chronic selenium poisoning, which was manifested by the loss of hair, 
as well as brittleness and white spotting of the fingernails. Skin lesions and abnormalities 
of the nervous system were also observed. 
The nature of selenium toxicity 
Early work suggested that selenium toxicity was due to the interaction of selenium 
with the thiols such as disulfides of proteins in the formation of selenotrisulfides 
(RSSeSR) (Ganther, 1968). Selenotrisulfides can be reduced by excess thiols or cellular 6 
glutathione reductase, forming highly reactive selenopersulfides (GSSeH) (Ganther et al, 
1971).  Selenium toxicity was suggested to be due to the reaction of selenite with 
glutathione and with H2Se to produce superoxide (02 ") (Seko et al, 1988). When the 
ability of animals to methylate excessive selenium is exceeded, this leads to selenosis, i.e., 
selenium toxicity (Saltman et al, 1989). Interestingly, metabolism of excessive selenium 
is necessary for its carcinostatic activity and evidence indicates that methylated forms of 
selenium are most effective against carcinogenesis (Ip, 1989). 
Dose-response relationship 
In the rats, the dietary requirement for selenium is about 0.2 ppm (Hafeman et al, 
1974). However, chronic dietary selenite toxicity begins at 3-4 ppm and there is almost 
no survival of rats fed 16 ppm selenium (Harr et al, 1967). Inhumans, both blood and hair 
selenium concentrations are a fairly reliable measure of selenium exposure (Longnecker 
et al, 1991; Yang et al, 1994). An epidemiological investigation of selenium consumption, 
accompanied by blood and hair concentrations, provided useful data in establishing the 
dose-response relationship and the adverse health effects in humans (Yang et al, 1983). 
Average daily dietary intake of 4.99 mg selenium corresponded to a mean blood selenium 
concentration of 3.2 gg/m1 for humans with chronic selenosis. Average daily intake of 750 
lig selenium corresponded to a mean blood selenium level of 0.44 µg/ml, but did not 
result in signs of selenosis. On the other end, an average daily intake of 11 ug selenium 
corresponded to a mean blood selenium level of 0.021 µg/ml, which resulted in Keshan 
disease. 7 
Differences were found in the gel filtration patterns of plasma from Chinese men 
living in selenium deficient, adequate and excessive areas of China (Xia et al, 1992). The 
majority of the selenium in plasma of men living in excessive selenium areas was 
associated with albumin, while most of selenium in plasma of men living in adequate or 
deficient areas was associated with selenoprotein P (Whanger et al, 1996). Studies with 
guinea pigs indicated that the percentage of selenium in the albumin fraction increased 
with elevated dietary levels as selenomethionine (see appendix A). 
Safe levels of selenium for humans 
Animals studies showed that 0.1-0.2 lig selenium/g of diet was adequate for 
mammalian species (Yang et al, 1989; Spallholz, 1994). Extrapolated to humans by 
including an uncertainty factor, a range of 50 to 200 .tg/day has been suggested as an 
adequate and safe level for adults in the United States. Establishing a safe level of 
selenium is a challenge because of its anticarcinogenic properties at subtoxic levels. Most 
selenium intake data suggest that upper limit of 200 lig selenium per day is a conservative 
one. Based on their studies of daily intake and using a safety factor of 10, Sakurai et al 
(1974) suggested 500 lig Se/day as a safe upper limit. McCary (1984) suggested a daily 
regimen providing 600 mg Se/day based on personal experience. Olson (1986) suggested 
that the maximum safe multiple oral dose as 5µg Se/day per kg body weight (equal to 
daily intake of about 500 µg selenium). 
The Chinese data have been used extensively to establish the maximal and minimal 
safe intakes and the dietary requirement of selenium for humans (Yang et al, 1989; Yang 8 
et al, 1994). A significant correlation was found between selenium intake and selenium 
levels in blood, milk, urine, hair, fingernails and toenails. Morphological changes in 
fingernails were used as the main criterion for clinical diagnosis of selenosis. It was 
suggested that the safe level of selenium for humans was about 400 mg per day. A level 
of about 40 pg daily was suggested as the minimum requirement and an intake of less than 
11 jig daily will result in selenium deficiency. 
SELENOPROTEINS AND THEIR FUNCTIONS 
Selenium is a unique essential trace element and in contrast to other elements can 
exist in five oxidation states. Its remarkable biological effects are related to unique 
functions in various selenoproteins. Almost all the selenium in animal tissues is associated 
with protein, but only one form, selenocysteine encoded by a UGA codon, is specific for 
this element and physiologically regulated. Proteins containing this form of selenium are 
referred to as selenoproteins, and selenocysteine has been called the 21st amino acid 
(Bock et al, 1991a). 
Selenium can undergo several metabolic fates under physiological conditions. A 
major one is incorporation into selenoproteins. By in vivo labeling with 'Se and 
separation by SDS-PAGE, a large number of selenium-containing proteins have been 
found in various rat tissues (Behne et al, 1988). Only a few eukaryotic selenoproteins 
have been characterized to the extent of cloning their cDNAs and determining their 
sequences. 9 
Glutathione peroxidase family (GPX) 
At least four types of glutathione peroxidase have been identified in different 
organs. These are cellular glutathione peroxidase  (cGPX) (Rotruck et al  1973), 
extracellular glutathione peroxidase (eGPX) (Takahashi and Cohen, 1986), phospholipid 
hydroperoxide glutathione peroxidase (phGPX) (Urisini et al, 1985), and gastrointestinal 
tract-specific glutathione peroxidase (GI-GPX) (Chu et al, 1993). All forms except 
phGPX have four identical subunits in which each contains one selenocysteine. 
cGPX was the first selenoprotein characterized in higher animals. It was the only 
known biological role of selenium for many years and has been used extensively to assess 
nutritional status of selenium. The enzyme catalyzes the reduction of hydroperoxide to 
eliminate potentially harmful peroxides, and thus selenium is classed as  essential for 
animals including humans (Rotruck et al, 1973; Tappel et al, 1984). cGPX exhibits some 
of the characteristics of a storage depot for selenium, and thus may serve as a biological 
selenium buffer which regulates selenium metabolism (Sunde, 1994). 
eGPX was recognized as another type of GPX in 1986 (Takahashi and Cohen 
1986).  It has  immunological, structural and functional differences from cGPX 
(Takahashi et al, 1987). Its function is not entirely clear. Although it can reduce hydrogen 
peroxide and organic hydroperoxides, it only utilizes reduced glutathione (GSH) as a 
reductant (Anderson et al, 1980; Cohen et al, 1994). 
Unlike other members of GPX family, phGPX is a monomeric enzyme (Schuckelt 
et al, 1991). Like cGPX, it catalyzes the reduction of hydroperoxides to corresponding 
alcohols using GSH as the reducing substrate (Ursini et al, 1985). However, phGPX can 10 
reduce phosphatidyl choline hydroperoxide, which is not a substrate for other  GPXs 
(Maiorino et al, 1982). 
The newest member of the GPX family is GI-GPX. It is the major form of GPX 
in rodent GI tract. The function is similar to cGPX;  to protect animals from 
hydroperoxide toxicity, especially in the GI tract (Chu et al, 1993). 
Iodothyronine 5'-deiodinase (DI) family 
Selenium is involved in thyroid hormone metabolism. Hypothyroidism caused by 
iodine deficiency worsens with selenium deficiency (Goyens et al, 1987). Intracellular 
concentrations of the thyroid hormones, thyroxine (T4) and 3,3',5-triiodothyronine (T3) 
are profoundly influenced by the activity of three iodothyronine deiodinases, classified as 
types I, II and III (Leonard et al, 1986; Behne et al, 1990). The discovery that all three 
types of DI are selenoproteins provided a link between selenium and iodine metabolism. 
Similar to the GPXs, selenocysteine is located in their active sites. The essential role for 
this trace element in thyroid hormone action is now firmly established. 
Type I-DI activity is highest in the thyroid, liver and kidney (Arthur et al,  1994). 
Its principle role in mammals is to catalyze conversion of the inactive form, T4, to its 
biologically active form, T3 (Leonard et al, 1986). Cloned cDNAs from rat (Berry et al, 
1991a), dog (Mandel et al, 1992) and human (Toyoda et al, 1994) contain in-frame TGA 
codon for selenocysteine, which is necessary for maximal enzyme activity (Arthur et al, 
1994). Selenium deficiency decreases type I-DI and impairs the conversion of T4 to T3 
(Leonard et al, 1986). 11 
Type II-DI is found in highest activity in the brain, brown adipose tissue and 
pituitary (Croteau et al, 1996). The primary function of this enzyme is to convert T4 to 
T3, or 3,3',5'-triiodothyronine (reverse T3 ) to diiodothyronine (T2 ), and regulate thyroid 
hormone action in these tissues (Arthur et al, 1994). Type II-DI was not considered a 
selenoenzyme until recently, cDNA cloned from R. Catesbein (Davey et al, 1995), human 
and rat (Croteau et al, 1996) indicated the presence of an in-frame TGA codon  . 
Type III-DI was confirmed as a selenoenzyme by sequencing cDNAs from 
Xenopus laevis tadpoles (Wang et al, 1993), R. catesbein (Becker et al, 1995) and the 
rats (Croteau et al,  1995; Ramauge et al,  1996). These cDNAs exhibit significant 
sequence homology to mammalian 51-DI cDNAs, including the in-frame TGA which 
codes for selenocysteine (Becker et al, 1995). This enzyme catalyzes T4 and T3 to their 
respective inactive forms rT3 and T2, and it is usually expressed in a tissue-specific pattern 
during development (Leonard et al 1986). The major function is assumed to prevent 
exposure of tissues to excessive levels  of active thyroid hormones (Visser and 
Schoenmakers, 1992). 
Selenoprotein P 
Selenoprotein P (SeP) is a glycoprotein that has been purified from rat (Yang et 
al, 1987) and human plasma (Akesson et al, 1994). It is the only selenoprotein known to 
contain multiple selenocysteines. Peptide analysis indicates that a selenium-rich region 
exists in SeP (Read et al,  1990). The sequences of cloned cDNAs predicted 10 
selenocysteine residues coded by UGA (Hill et al 1991; Hill et al,  1993). 13 
(Beilstein et al, 1996). SeW is assumed to have the relationship with muscle metabolism, 
because failure to incorporate selenium into this protein in selenium deficient lambs is 
associated with the myopathy (Pedersen et al, 1972). In normal animals, however, SeW 
levels were highest in muscle tissues (Yeh et al, 1995; 1997). 
Mammalian thioredoxin reductase 
Recently a new selenoprotein purified from human lung adenocarcinoma cells was 
shown to be a homodimer of 57 KDa subunits containing FAD and selenocysteine 
located in a C-terminal tripeptide-cys-secys-gly (Tamura and Stadtman,1996).  This 
enzyme exhibited thioredoxin reductase (TR) activities similar to those of human placenta 
(Oblong et al, 1993) and rat liver (Luthman et al, 1982) TRs. Examination of rat liver 
thioredoxin reductase revealed the presence of about 0.75 equivalents of Se per enzyme 
subunit (Tamura et al, 1996). The TGA codon in the cloned human placental thioredoxin 
reductases gene was interpreted as a stop codon (Gasdaska et al, 1995), but a 12 residue 
75Se-labeled tryptic peptide isolated from human T-cell TR was shown to contain 
selenocysteine in the position corresponding to a TGA codon in the human placental TR 
gene (Gladyshev et  al,  1996). All available evidence indicates that this classical 
mammalian thioredoxin reductase is also a selenoenzyme (Tamura et al, 1996). 
Other possible selenoproteins 
In addition to the selenoproteins already characterized at the molecular level, there 14 
is evidence for a number of other ones (Behne et al,  1988). Evidence for a new 
selenoprotein recently found in the glandular epithelial cells of the rat prostate is one 
example (Kalcklosch et al, 1995). The molecular weight of this protein is about 15 KDa, 
and selenium is present in the form of selenocysteine (Kalcklosch et al, 1995). When 
selenium supply is limited, selenium is preferentially incorporated into this protein instead 
of GPX (Kalcklosch et al,  1995).  Although this selenoprotein has not been fully 
characterized, the inverse relationship between selenium and the incidence of prostatic 
cancer implies that a selenoprotein could have specific sites of action in this tissue. 
Mitochondrial capsule selenoprotein (MCSP) was once considered a tissue-
specific selenoprotein with multiple selenocysteines (Karimpour et al, 1992). However, 
recent sequences of a human MCS cDNA encoding a 116-amino-acid protein (Aho et al, 
1996) and a rat MCS cDNA encoding a 145-amino-acid protein (Adham et al, 1996) did 
not indicate any in-frame UGA codons. Thus, MCS is not a selenoprotein. 
SELENOPROTEIN BIOSYNTHESIS 
The in-frame UGA codon which directs a selenocysteine moiety into protein exists 
in both prokaryotes and eukaryotes (Bock et al, 1991b; Berry and Larsen, 1993). 
Elucidation of the overall feature governing the highly specific insertion of the unusual 
amino acid, selenocysteine, into a few selenium-dependent enzymes has opened up an 
exciting new area in selenium biochemistry. Using genetic and biochemical approaches 
in bacteria,  significant progress has been made to characterize the process of 15 
selenoprotein synthesis in prokaryotes (Bock et al, 1991b; Heider et al, 1992; Ringquist 
et al, 1994). By contrast, relatively little is known about eukaryotic selenocysteine 
incorporation. A similar mechanism of selenocysteine incorporation into eukaryotic 
selenoproteins has been proposed (Low and Berry, 1996; Martin et al, 1996). The cis-
acting mRNA selenocysteine insertion sequence (SECIS) elements have been found in the 
3' untranslated regions of eukaryotic selenoprotein mRNAs (Berry et al, 1993); an 
analoguous specific tRNA recognizes the UGA codon (Hatfield,  1985), and 
selenocysteine is synthesized from serine esterified to this RNA (Lee et al, 1989); but the 
lack of a corresponding series of mutants has prevented elucidation of the overall process 
(Stadtment, 1996). 
Cotranslational incorporation of selenocysteine 
Studies with bacteria indicated that the activity of formate dehydrogenase was 
undetectable when grown in medium without selenium (Stadtman et al, 1980). This was 
the first clue that  selenoprotein synthesis was selenium-dependent.  In 1986, it was 
discovered that two genes, one coding for E. coli formate dehydrogenase (Zinoni et al, 
1986), and the other encoding mouse glutathione peroxidase (Chambers et al, 1986), 
contained in-frame UGA codons. These observations suggested a cotranslational mode 
for incorporation of the non standard amino acid, selenocysteine, into selenoproteins. In 
the absence of selenium, decoding of the selenoprotein mRNA pauses or terminates at the 
UGA codon (Leinfelder et al, 1988).  Selenocysteine in GPX is derived from serine, 
which provides the carbon skeleton for selenocysteine (Sunde and Evenson, 1987). 16 
However,  direct proof of cotranslational incorporation of selenocysteine into 
selenoproteins came from experiments in bacteria. A reporter gene, lacZ, was fused 
downstream of the portion of thefdhF gene containing the UGA codon. Translation of 
lacZ mRNA and production of [3-galactosidase occurred only (1) when selenium was 
present in the medium and (2) when a functional pathway of selenocysteine biosynthesis 
and incorporation was present (Zinoni et al, 1987). The cotranslational incorporation of 
selenocysteine into selenoprotein was finally established. 
Selenoprotein synthesis in prokaryotes 
Incorporation of selenocysteine into protein is a complex process. In prokaryotes, 
the mechanism has been elucidated by utilizing E. coli mutants. Both trans-acting factors 
and cis-acting elements  are required for successful cotranslational incorporation of 
selenocysteine into protein (Burk and Hill, 1993). Four unique components produced by 
selA, selB, seIC and selD, act as trans-acting factors for selenoprotein synthesis 
(Leinfelder et al, 1988). 
First, a unique tRNAse` containing the anticodon for UGA is aminoacylated with 
serine by seryl-tRNA synthetase (Forchhammer et al, 1991). Subsequently, selenocysteine 
synthase (SELA), a pyridoxyl 5-phosphase enzyme, catalyzes the replacement of the side 
chain oxygen in serine by selenium, yielding selenocysteine (Forchhammer and Bock, 
1991).  The selenium donor is selenophosphate which is synthesized by an enzyme, 
selenophosphate synthetase (SELD) (Kim et al, 1992; Glass et al, 1993). Finally, the 17 
selenocysteine-specific translation factor (SELB), which is homologous to EF-Tu, 
exclusively binds to selenocysteyl-tRNA"c (Bock, 1994). 
In addition to the trans-acting factors, a stem-loop structure with a specific 
sequence on the loop is located immediately downstream of the UGA selenocysteine 
codon in prokaryotic selenoprotein mRNAs (Heider et al, 1992). This acts as a SELB 
recognition motif, leading to the formation of a quaternary complex of SELB, GTP, 
selenocysteyl-tRNAsec, and the mRNA stem-loop (Heider and Bock 1992). These cis-
acting elements are both necessary and sufficient to drive selenocysteine incorporation at 
the UGA codon of prokaryotic selenoprotein mRNAs instead of termination (Zinoni et 
al, 1990). 
Selenoprotein synthesis in eukaryotes 
Deciphering of the UGA selenocysteine codon for selenoprotein synthesis in 
eukaryotes appears to use a specific mechanism different from that found in prokaryotes. 
By using modern molecular biology techniques, great efforts have been taken to elucidate 
this complex process. Although the detailed mechanism is  still unclear, several 
components of the selenoprotein translational machinery have been identified. 
Selenocysteine insertion sequence (SECIS) 
A stem-loop structure in the mRNA coding for selenoproteins is essential to 
mediate proper interpretation of the selenocysteine UGA codon. In prokaryotic mRNAs, 
this stem-loop structure is located immediately downstream of the UGA codon. In 
contrast, this stem-loop structure, called the selenocysteine insertion sequence (SECIS) 18 
element, resides in the 3'-untranslated region (3'-utr) downstream of the UGA codon in 
eukaryotic mRNAs (Berry et al, 1991b; Hill et al, 1993; Shen et al, 1993). The distance 
between a SECIS element and a UGA codon determines whether the UGA is read as a 
termination or a selenocysteine codon. In deiodinase mRNA, a UGA 111 bases from the 
SECIS element can be read as a selenocysteine, but a UGA separated from a SECIS 
element by 51 bases is read only as a stop codon (Martin et al, 1996) 
Functional SECIS elements were identified in the 3'-utr of the rat type I 5' DI, 
GPX and SeP mRNAs (Berry et al, 1991b; Berry et al, 1993). Site-directed mutational 
analysis indicated that certain conserved features are essential for function (Berry et al, 
1993; Shen et al, 1995). These include an AUGA sequence in the 5' arms, an UGA 
sequence in the 3' arms of the stems, and an AAA sequence in or near the apical loops. 
In addition, deciphering of the UGA selenocysteine codon into a reporter gene, the 
luciferase gene, has been utilized to further probe the role of the SECIS element in 
selenocysteine incorporation into protein (Kollmus et al,  1996).  This latter study 
suggested that the precise sequences of the SECIS elements are relatively unimportant as 
long as length and thermostability of the base-paired structures are retained. 
Further study of the secondary structure of SECIS elements by Walczak et al 
(1996) indicates a novel RNA structural motif in the SECIS elements of eukaryotic 
selenoprotein mRNAs. It is characterized by a stem-loop structure, comprised of two 
helices (I and II) separated by an internal loop, with an apical loop surmounting helix II. 
Sequence comparisons of 20 SECIS elements from two 5'-DI, thirteen GPX, two SeP, 
and one selenoprotein W mRNA confirm the model (Walczak et al ,1996) . A short 19 
stretch of conserved sequences in helix II, which interact to form a novel RNA structural 
motif, consists of a quartet of non-Watson-Crick base pairs 5'UGAT3': 5'UGAU3' 
(Walczak et al ,1996). Furthermore, a three dimension model derived by computer 
analysis indicated a quartet lies in an accessible position at the foot of helix II, which 
suggests that the non-Watson-Crick base pair arrangement provides an unusual pattern 
of groups that can interact with putative ligands (Walczak et al ,1996). 
Selenocysteyl specific t-RNA 
Selenocysteyl-tRNA is a central component of selenoprotein biosynthesis in 
eukaryotes. The sec-tRNAs have been sequenced and found to consist of 90 nucleotides, 
making them the longest eukaryotic tRNAs (Lee et al, 1990; Diamond et al, 1993)  . 
Despite the conservation of function for selenocysteyl-tRNA in both prokaryotes and 
eukaryotes, significant differences in structure and biological regulation exist (Hatfield et 
al, 1994). The uniquely long aminoacyl acceptor stem of eukaryotic tRNAs constitutes 
one structural determinant crucial for the serine to selenocysteine conversion step 
(Sturchler-Pierrat et al, 1995). Eukaryotic sec-tRNA may play a dual role, serving as 
carrier molecules for synthesis of selenocysteine as well as an adaptor for the 
incorporation of selenocysteine into protein (Hatfield et al, 1994). 
Eukaryotic tRNA(s")"c is first charged with serine by conventional seryl-tRNA 
synthase and has been recovered in three forms with either serine, phosphorylated serine 
or selenocysteine attached (Lee et al, 1989). It has been presumed that selenocysteyl­
tRNA in mammals was biosynthesized from seryl-tRNA by conversion of the serine 20 
moiety through the intermediate, phosphoser-tRNA (Lee et al, 1989). Other evidence 
suggests that a selenocysteine synthase, similar to E. coli SELA, directly converts seryl-
tRNA*4s" to sec-tRNA("r)see using HSe" as a selenium donor. ATP, and another protein, 
similar to E. coli SELD (Mizutani et al, 1992) are required in this process. From this 
point of view, the mechanism of sec-tRNA synthesis in eukaryotes is the same as those 
in prokaryotes.  However, 31P NMP (Nuclear Magnetic Resonance) spectroscopy 
indicated that the labile selenium donor compound is selenophosphate (Veres et al, 1992). 
The enzyme selenophosphate synthetase (Kim et al, 1995) may be involved in sec-tRNA 
conversion and thus selenophosphate would serve as an intermediator. The precise 
mechanism of selenocysteine biosynthesis in mammalian cells has not been resolved. 
However, the selenocysteylation process requires the long aminoacyl acceptor stem in 
tRNA(ser)sec, which is unique to this tRNA (Lee et al, 1996). 
Analog of SELB factors 
The fundamental difference between prokaryotic and eukaryotic selenocysteine 
incorporation is that the RNA stem-loop is located immediately 3' to the UGA codon in 
the former, but the SECIS element resides in the 3'-utr of eukaryotic mRNAs. A specific 
translational machinery is needed to direct the selenocysteine into the UGA codon. Much 
effort has been focused on the search for potential proteins, similar to bacterial SELB 
elongation factor, involved in the combined recognition of the UGA in the coding region 
and the SECIS element in the 3'-utr to allow selenocysteine insertion. 21 
One such candidate is a 48 KDa protein recognized by the antibodies from 
autoimmune chronic active hepatitis (Gelpi et al, 1992). This protein bound selenocysteyl 
tRNA but did not exhibit tRNA synthetase activity. The second candidate, SELB like 
factor named sec-tRNA protecting factor (SePF), is a 50 KDa protein from bovine liver 
extracts (Yamada et al, 1994).  This protein can protect selenocysteyl-tRNA against 
alkaline hydrolysis (Yamada et al, 1994) and also bind to UGA-programmed ribosomes 
(Yamada et al, 1995). The third candidate, at least two proteins, with estimated molecular 
masses of 55 KDa and 65 KDa was isolated from COS-1 cell extracts (Shen et al, 1995). 
Both proteins can bind the SECIS element from human GPX1 transcripts through the 
basal stem region, while the upper stem loop and two of the three short conserved 
sequences appear to contribute to the affinity of the binding (Shen et al, 1995). The 
newest candidate, SECIS binding protein (SBP), is a protein with molecular weight of 60­
65 KDa (Hubert et al, 1996). Mobility shift assays indicate that SBP is present in different 
types of mammalian cell extracts and possesses the capability of binding the SECIS 
element of the selenoprotein GPX mRNA (Hubert et al, 1996). Competition experiments 
attested that the binding is highly specific. SBP is the eukaryotic analog to SELB, a 
component of the eukaryotic selenoprotein translational machinery (Hubert et al, 1996). 
SELENOPROTEIN REGULATION 
Unlike any other metal-binding protein, selenoproteins are synthesized by 
cotranslation of selenocysteine into protein at the UGA codon, using inorganic selenium 
as the selenium source. Selenocysteine incorporation itself is a unique way for controlling 22 
selenoprotein synthesis, which is greatly dependent on the available selenium. As far as 
is known, selenium deficiency down regulates all selenoproteins in higher animals. 
Several steps could be involved. 
mRNA levels 
Regulation of selenoprotein mRNA accumulation could  occur  at the 
transcriptional or post-transcriptional level. The effect of selenium on cGPX mRNA has 
been studied extensively. The guinea pig, with a cGPX gene highly homologous to the 
rat, shows extremely low GPX activity and very low levels of mRNA in the liver, kidney 
and heart in comparison to the GPX activity and mRNA levels in the same rat tissues 
(Toyoda et al, 1989). Tissue specificity of GPX expression in guinea pigs is due to the 
difference in the transcriptional rate as determined by nuclear run-on assay (Himeno et 
al, 1993). Work by others was performed in selenium-deficient rats to examine the tissue-
specific regulation of cGPX, phGPX and type I 5'-DI gene expression, and they found 
that regulation of the three mRNA accumulation and subsequent protein synthesis 
between liver, thyroid and heart are differences (Bermano et al ,  1995). The levels of 
selenoenzyme mRNAs did not always parallel the changes in enzyme activity, suggesting 
a distinct mechanism for regulating mRNA levels (Bermano et al  1995). 
mRNA levels of all the genes for GPX, 5'-DI and SeP in animals fed selenium-
deficient diets decreased, but mRNA levels quickly recovered with selenium repletion 
(Tokoda et al, 1989). Additional nuclear run-on studies demonstrated that the decrease 
in mRNA levels of GPX, 5'-DI and SeP due to dietary selenium deficiency is not caused 23 
by a change in the efficiency of nuclear RNA synthesis, but the decrease is probably due 
to the accelerated degradation of the RNA  transcripts (Burk et al, 1994, Bermano et al, 
1995). Compatible evidence was also obtained from in vitro studies. The human GPX 
gene expression in the HL-60 human myeloid cell line is regulated post-transcriptionally 
in response to selenium availability (Chada et al, 1989). Work with L8 rat skeletal muscle 
cells suggests that the effect of selenium in the culture medium on selenoprotein W gene 
transcription also resides at the post-transcriptional level (see chapter 5). 
Effects on UGA readthrough 
The efficiency of selenocysteine incorporation into selenoproteins is another step 
for selenoprotein regulation. A number of factors are involved to ensure the UGA  codon 
readthrough. Selenium status could affect one or more of these factors and subsequently 
change the efficiency of UGA decoding. 
The amount of full length 5D1 protein was severely decreased in animals and in 
transiently transfected human embryonic kidney 293 cells when selenium is limited (Berry 
et  al,  1994; Depalo et  al,  1994). Truncated peptide synthesized intracellularly 
demonstrates that UGA can serve as both a stop and a selenocysteine codon in a single 
mRNA. This is also true for in vitro studies with glutathione peroxidase mRNA  which 
indicated that the coding UGA codon can serve as a terminator (Jung et al, 1993). Even 
though SeP mRNA utilizes UAA to specify termination, the presence of selenoprotein P 
isoforms in rat plasma indicated that the second UGA codon in selenoprotein P mRNA 
can have alternative functions coding for the incorporation of selenocysteine or for 24 
termination of translation (Himeno et al,  1996). Selenium status could affect the 
tRNA(ser*c population in mammalian cells (Hatfield et al, 1991). Recently, the search for 
a eukaryotic SELB analogs suggested that some proteins may be  involved in 
selenoprotein insertion via RNA-protein, and protein-protein interactions (Shen et al, 
1995; Hubert et al, 1995). It is probable that selenium status first affects one or more of 
these factors and consequently changes the assembly of translational machinery leading 
to decreases in the UGA readthrough. Alternatively, selenium deficiency could affect 
the SECIS element via intermediate factors and change the efficiency of UGA decoding. 
Protein levels 
Either down-regulation or up-regulation of selenoproteins with either selenium 
deficiency or selenium supplementation have been demonstrated in various animal studies 
(Knight et at 1988; Read et al, 1990; Burk et al, 1991) and in humans population (Hill et 
al, 1996a). Selenoprotein levels are more sensitive to selenium status than their mRNA 
levels, and the effects of selenium on mRNA levels are not always in parallel with 
selenoproteins levels. Such as cultured HL-60 human myeloid cells deprived of selenium 
exhibit a fall in cGPX activity without a concomitant fall in its mRNA (Chada et al, 1989). 
mRNA values of GPX, SeP and SeW fell, in response to selenium deficiency  respectively 
to 3%, 11% and 25% of selenium-adequate values (control), but cGPX activity was 0.8% 
of control (Chada et al, 1989), SeP concentration 4.3% of control (Hill et al, 1992) and 
SeW concentration 12.5% of control (Vendeland et al, 1995). Selenium deficiency causes 
a decrease in the concentration of all selenoproteins, but not to the same extent. 25 
Increasing the level of selenium has the general effect of elevating selenoprotein synthesis. 
There is no evidence that selenium status affects the turnover of selenoproteins and thus 
the regulation of selenoproteins by selenium is considered to be at the translational level 
rather than at the post-translational step. 
The brain appears to be unique with respect to the effects of dietary selenium on 
both selenium metabolism and selenoprotein biosynthesis. With selenium deficiency, there 
are parallel substantial losses of selenium and selenoproteins in most tissues, except for 
the brain. Prohaska et al (1976) found that the maintenance of rats on a low selenium diet 
for 13 weeks had no effect on brain GPX activity. Later, other workers also found that 
brain GPX is not sensitive to selenium deficiency (Behne et al, 1988; Buckman et al, 
1993). Consistent with these findings, another selenoprotein, selenoprotein W, remained 
at the same level in brain from sheep fed a selenium deficient diet as compared to those 
fed a selenium supplemented diet (Yeh et al, 1997a). The unique nature of selenium 
metabolism and selenoprotein synthesis in brain might be explained either by sequestration 
of limited supplies of dietary selenium or by preferential use of a limited pool of selenium 
for selenoprotein biosynthesis in this organ. 
The mechanism for regulating selenoprotein synthesis  is  not completely 
understood. The relative efficiencies of the SECIS elements in SeP, 5'-DI and GPX are 
consistent with their order of appearance upon selenium repletion in selenium depleted 
animals (Hill et al 1991). This selective incorporation may also play a role in the organ-
specific expression hierarchies for selenoproteins. 26 
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ABSTRACT 
SECIS elements form stem-loop structures in the 3' untranslated regions of 
eukaryotic mRNAs that encodes selenoproteins. These elements direct incorporation of 
selenocysteine at UGA  codons, provided the SECIS element lies a sufficient distance from 
the UGA. The cDNAs for skeletal muscle selenoprotein W from human, rhesus monkey, 
sheep, rat, and mouse contained highly similar SECIS elements that retained important 
features common to all known SECIS elements. Comparative analysis of these SECIS 
elements showed that in some regions both predicted secondary structure and nucleotide 
sequences were conserved, in other areas secondary structure was maintained using 
different primary sequence, and in still other portions, base paring was not conserved. 
The rodent and sheep selenoprotein W mRNAs used UGA  as a stop codon and a 
selenocysteine codon.  This,  UGA  specified both selenocysteine incorporation and 
termination in a single mRNA.  The selenoprotein W SECIS elements contained an 
additional highly-conserved base-pair stem that may prevent inappropriate selenocysteine 
incorporation at the UGA stop codons. 41 
INTRODUCTION 
The functions of several selenoproteins have been determined within the last 
several years, and the cDNAs encoding a number of vertebrate selenoproteins have been 
sequenced. These include cellular glutathione peroxidase (GPX) from humans 
(Mullenbach et al, 1987), rats (Ho et al, 1988), mice (Chambers et al, 1986), and cattle 
(Mullenbach et al, 1988), human plasma GPX (Takahashi et al, 1990), phospholipid 
hydroperoxidase GPX (Schuckelt et al, 1991), GPX from intestinal tract (Chu et al, 
1993), types I (Berry et al, 1991a), II (Davey et al, 1995), and III (Croteau et al, 1996) 
iodothyronine deiodinases, rat plasma selenoprotein P (Hill et al, 1991), and rat skeletal 
muscle selenoprotein W (Vendeland et al, 1995). Like selenoprotein P, the metabolic 
function of selenoprotein W is unknown. However, based on the activities of known 
selenoenzymes, selenoprotein W may be involved in oxidation-reduction (Burk and Hill, 
1993). This possibility was strengthened by the discovery that selenoprotein W binds 
glutathione (Beilstein et al, 1996), a compound often associated with antioxidant proteins. 
Selenium deficiency results in white muscle disease, a muscular and cardiac 
degeneration in lambs and calves (Schuber et al, 1961). A severe nutritional selenium 
deficiency in discrete areas of China caused an endemic juvenile cardiomyopathy called 
Keshan disease (Chen et al, 1980).  Selenium supplementation can reverse muscle 
weakness in patients depleted of this element by long term parenteral nutrition (Brown 
et al, 1976). Thus, there is substantial evidence that selenium is important for normal 
skeletal and cardiac muscle metabolism. The role of selenoprotein W in white muscle 42 
disease remains unknown, but because it  is present in normal muscle at a higher 
concentration that in any other tissues (Yeh et al, 1995), it may play an important role in 
muscle metabolism. 
In all known selenoproteins, selenocysteine is encoded by UGA. Although UGA 
is usually a stop codon, it also directs incorporation of selenocysteine into selenoproteins 
(for reviews see Stadman, 1990; Berry et al, 1991b; Low and Berry, 1996). A unique 
tRNA serve as the site of selenocysteine synthesis from serine and recognizes the UGA 
in the mRNA (Leinfelder et al, 1989). In eukaryotic mRNAs, interpretation of UGA as 
a selenocysteine codon requires a SECIS element, which forms a conserved stem-loop 
structure in the 3' untranslated region of the mRNA (Berry et al, 1993; Hill et al, 1993; 
Shen et al, 1993). Spacing between UGA codons and SECTS element determines whether 
a particular UGA specifies selenocysteine or a stop (Martin et al, 1996). 
Recently, we purified and characterized selenoprotein W from rat skeletal muscle 
(Vendeland et al, 1993), isolated the corresponding cDNA, and determined its sequence 
(Vendeland et al, 1995). This paper presents the human, rhesus monkey, sheep, and 
mouse cDNA sequences for selenoprotein W from skeletal muscle. These cDNA and 
deduced protein sequences were highly conserved, suggesting that selenoprotein W has 
an important function. All selenoprotein W cDNAs contained similar SECIS elements 
with both conserved and novel features. Alignments of these SECIS elements identified 
highly conserved regions where both secondary structure and primary sequence are 
probable important for activity. This analysis also observed weakly conserved regions 
that likely do not play an important role in SECIS function. 43 
MATERIALS AND METHODS 
c DAN libraries 
Total RNAs for skeletal muscle were isolated from rhesus monkey, sheep and 
mouse tissues. Double-stranded cDNAs were synthesized respectively from poly(A)+­
enriched RNA isolated from above species by reverse transcription with oligo (dT) 
primers, and constructed in the lambda Ex Cell EcoRI/CIP vector (Pharmacia) as 
described (Vendeland et al, 1995). Rats and mice ate a diet with one ppm selenium for 
ten days before the hind leg muscle was collected for RNA extraction. Muscle was taken 
from a sheep fed, for three months, a diet containing three ppm selenium. The Oregon 
Primate Center supplied rhesus monkey muscle; the monkey ate a standard diet prior to 
tissue collection. A human skeletal muscle cDNA library constructed in the lambda Maxl 
Vector was purchased from Clontech (Palo Alto, California). 
Probes 
Probes were prepared from a cloned rat selenoprotein W cDNA by PCR and used 
to screen human, monkey, sheep and mouse cDNA libraries plated at approximately 
20,000 plaques per 150 mm plate.  Digoxigenin-labeled dUTP was incorporated into 
probe DNA during PCR using standard conditions (DIG DNA Labeling Kit, Boehringer 
Mannheim), Plaques were lifted onto a nylon membrane and hybridized with digoxigenin 
antibody in conjunction with the chemiluminescent substrate CSPD (Boehringer 
Mannheim). Four or more independent clones were isolated from each library. 44 
Sequence analysis 
The cDNA inserts were excised in vivo from the lambda Ex Cell and Maxl vectors 
as inserts in the pExCell and pYEUra3 phagemids, and plasmid DNA was purified for 
sequencing. DNAs were sequenced in an Applied Biosystems 373A automated DNA 
sequencer. From each library at least four clones were sequenced. Sequence analyses 
were performed with the Genetics Computer Group Sequence Analysis Software 
Package, version 7.2-UNIX. RNA secondary structure predictions for the putative 
selenoprotein W SECIS elements were performed with the GCG programs RNA Fold and 
Squiggles. 
RESULTS AND DISCUSSION 
Selenoprotein W cDNA sequences 
Figure 2-1 presents the selenoprotein W cDNA sequences for five species. The 
cDNAs isolated independently from the same species were of similar lengths, varying by 
five bases or less at their 5' termini. Thus, the cDNA sequences appear to represent full-
length, or nearly full-length, copies of the mRNAs. The sequences shown in figure 2-1 
are the longest obtained for each species. The sheep library yielded two different cDNAs. 
Of four sheep cDNAs sequenced, each variant appeared twice. Differences in orientation 
and lengths of the 5' untranslated sequences and 3' polyadenylations showed that each of 
these cDNA clones was independent. The alternate sheep sequence differed from the 
sequence in figure 2-1 at six sties (see figure legend). One of these base changes created 45 
Human  CAGGTGGGAG GTTAGTGTGG CCCGGGCGTC CGCTCCTCAG CGGATGTGGC AGCCCCGAGC C  61
 
Monkey  T GA AGC ATGT  T  A
  G  55
 
Rat  TGCT CTA T TGGTC G  T G T TGT GC GG AT  GA GTGC  A  51
 
Mouse  T GGGTC G  T GTG TGT GC GG AT  GA GTGC  T  43
 
Sheep  TCT CTTCGC CCGG  TC
  AT  A A  G TG  GCACC  G T AG  T  61
 
Human  ATG GCT CTC GCC GTC CGA GTC GTT TAT TGT GGC GCT TGA GGC TAC AAG TCC 112
 
Monkey ATG 
Rat  ATG  G  A 
G 
T  G  A 
TGA 
TGA  T  C 
106 
102 
Mouse  ATG  G  T  G  A  TGA  T  C  94 
Sheep  ATG  G G  T  A  TGA  C  112 
Human  AAG TAT CTT CAG CTC AAG AAG AAG TTA GAA GAT GAG TTC CCC GGC CGC CTG 163
 
Monkey
  157
 
A T
 
Mouse  C C  G C
 
Rat  C  G C C  153
 
C  A T  145
 
Sheep
  T A  T T  163
 
GAC ATC TGC GGC GAG GGA ACT CCC CAG GCC ACC GGG TTC TTT GAA GTG ATG 214
 
Monkey
 
Human
 
A  208
 
Rat T G  C
 T  204
 
Mouse T T  G  T
  CA 196
 
Sheep  G
  T  C  T C 214
 
Human  GTA GCC GGG AAG TTG ATT CAC TCT AAG AAG AAA GGC GAT GGC TAC GTG GAC 265
 
259
 Monkey
 
Rat
  G  C  G T  T 255
 
Mouse  G C  T  T 247
 G T
 
Sheep  G A  C G  C  GG  265
 
Human  ACA GAA AGC AAG TTT CTG AAG TTG GTG GCC GCC ATC AAA GCC GCC TTG GCT 316
 
Monkey  C  C 310
 
Rat  G  C G A C  A T  306
 
Mouse  G  C G A C  A  T  298
 
Sheep  G  G
  T  316
 
Human  CAG GGC TAA TGC GCCCTGAAGG CAGAGTCCAG GGACCTT-GA CCCAGCCCCT CTCAGCAGAC 377
 
Monkey  TAA  A  C  - 371
 
Rat  T  C G TGA  AG  GGG  CT  AAGG  CCTG G  G C TTT CTTG CA C  368
 
Mouse  T  C G TGA  AG  GGG  CT  AAAG CCTG G  G C TTC CTTG CA C  360
 
Sheep  C  TGA  T  A A TA  G- G  g  377
 
Human  GCTTCATGAT AGGAAGGACT GAAAAGTCTT GTGGACACCT GGTCTTTCCC TGATGTTCTC 437
 
Monkey  ATGA  AAA  G  TGA  431
 
Rat  ATGAC A  AAAT  C AAA  CTG  TT CGA  -CT 427
 
Mouse  ATGAC A  AAAT  CTG  1 CGA  CT 418
 
Sheep  ATGAC  AAAT  C T  G  f  T TGA  437
 46 
496
 
Human  GTGGCTGCTG -TTQQQQQCA GAGATTGACG CCCCCGGTO: TTGCCTCTGA GCGGGAGAGT
 
T  T  488
 g T
 Monkey
  A  482
 G  TT CTGIGT  GG G  TCCC
 
Mouse  C G CA CA AC CA  C  G  TT CTGGCT  GG G  CCCC  A  473
 Rat  C G CA CA AG CA  C
 
A  T T  G C T T T T  496
 
AC  C C -G T A  G
 Sheep
 
Human  CTGTGTGTAT GTGTCTTCCC CGGAATCCAC ACCACCCCAC CCTCCTCCTG TCCCGTGGTT 556
 
C  548
 
Monkey
 
G  G C TCC CG  C CT C 523
 GC AC
 Rat  ACC
 
G  TG  G C  CC  G  C CT C 514
 
ACCC  GC AC
 
TG CA G TGGT  TGGTG
 
Mouse
 
T C  A CCC  545
 
Sheep  GA  C G
 
Human  TCATCATATC TCTTTGCATA CCCCATGTCT TCCCCAGTTG TCCCCTGGAG TTTGGGGGGA 616
 
607
 
Monkey  G C
 
CA- G  T  T CC T C  T CT CT  G TTTCCC 580
 
Rat  CTCA C C  A  T
 
CCCA C  T CT CT  GCIT1'CCC  574
 
Mouse  C CA C C  C  A T  CAT G  T
 
T 605
 C CCA  GT T CC  C  A  TG  G CT
 Sheep  CATCTCCC G CA C C  CC G
 
Human  CATCCCGCCT CAGGCATCCT TCTCAAGGGG AAGCCAAGAG AGGCATCAGG ATGGGTGGGT  676
 
A  667
 
Monkey  G
  615
 
GTCT  C  A AC G A AGAAG C  C
 
Mouse  -T T A  A AC G A AGAAG CA  C  608
 
G  GA G  A A  665
 
Rat
 
Sheep  GG  T TC  T  T
 
Human  TTCTGATTGT GGCAACGTTT GCAACCGTTC ACGATTCAAT AAATATTGGA TGAAATTAAC  736
 
AAT AAA  C  G  T G  727
 
Monkey  C G  A
 
GAAT AAAGG  C CA GGCA C  661
 GT  CG 'C  GGT  CT G
 Rat 
T  C  GGT  C  G  GAAT AAAGT  GG A A 654
 
Mouse
 
AAT AAA GG  AT GAGGT A A 725
 
Sheep  C  A  TC AA GT A G  A C  A C
 
Human  CGGAAAAAAA AAAAAAAAAA AA  758
 
Monkey  AAAAAAAA AAAAAAA--- -- 744
 
Rat  T AAAAAAAA A
  672
 
Mouse  AAAAAAAAAA AAAAAAAAA­ 673
 
Sheep  AAAA  729
 
Figure 2-1. Selenoprotein W cDNA sequences. The complete human cDNA sequence 
is shown, with the coding region presented as codon triplets. Bold type denotes: a) start 
(ATG), selenocysteine (TGA), and stop (TAA or TGA) codons, b) conserved SECIS 
motifs (ATGA, AAA, and TGA), and c) the polyadenylation signal (AATAAA); these 
elements are shown for all five species. Underlined bases indicate predicted base pairs in 
the SECIS stems. For the monkey, rat, mouse, and sheep cDNAs, bases are shown only 
where they differ from the human sequence. Selenoprotein W cDNA sequences are in the 
Gene Bank database under numbers U67171 (human), U67450 (monkey), U67853 
(sheep), U25264 (rat), and U67890 (mouse). A second sheep selenoprotein W cDNA 
differed from the sequence presented in this figure at six sites: C instead of T at bases 88 
and 427, A instead of G at base 528, C instead of A at base 563, T instead of C at base 
640, and G instead of A at base 677. One mouse cDNA had T instead of G at base 591. 47 
a restriction fragment length polymorphism: the sequence in figure 2-1 contains a BanI 
restriction site (GGTGCC; bases 528 to 533) not present in the alternate sequence 
(AGTGCC). Only one of the mutations, at position 88, occurred in the open reading 
frame; however, it did not change the amino acid (tyrosine) coded at that position. 
Another mutation, at position 427, lies within the SECIS element; the allele shown in 
figure 2-1 extended a predicted stem, but the other sheep allele had a primate-like 10-bp 
stem. The other four base changes also occurred in the 3' untranslated region, but outside 
the SECIS element, and probably do not affect the function of the mRNA. 
SECTS elements 
The putative SECIS elements found in the 3' untranslated regions of the six 
selenoprotein W cDNAs contained sequences and structures common to other well-
characterized SECIS elements (figure 2-2A). From I SECIS elements (for review, see 
Low and Berry, 1996) found in cDNAs for other mammalian selenoproteins (GPX, type 
1 iodothyronine deiodinase, and one selenoprotein P SECIC element) contain three 
conserved features that are necessary for SECIS function: an apical loop containing three 
A nucleotide separated by a 10 tp 12-bp stem from an AUGA in the 5' arm of the element 
and a GA dinucleotide in the 3' arm (Berry et al, 1993; Hill et al, 1993; Shen et al, 1993). 
Although the AUGA motif cannot form Watson-Crick base pairs with the GA 
dinucleotide, ribonuclease and chemical probing of cellular GPX and type 1 iodothyronine 
deiodinase SECIS elements shows that bases participate in non-Watson-Crick base 
interactions (Walczak et al, 1996). Figure 2-2B presents two proposed structures for 48 
these base interactions (Low and Berry, 1996; Walczak et al,  1996).  The bases 
immediately below the AUGA-GA region are unpaired (Walczak et al, 1996); however, 
base-paired stems of various lengths from below this region (Martin et al, 1996; Walczak 
et al, 1996; Kollmus et al, 1996; Shen et al, 1995). 
The role of these basal stems is controversial. A type 1 deiodinase SECIS element 
remains fully active when the entire basal stem is replaced by a five-base-pair stem 
comprised in its 5' arm of foreign sequence (Martin et al, 1996). In addition, extension 
of the 7-bp basal stem of a minimal selenoprotein P SECIS element enhances its activity; 
length of the stem, rather that its sequence or predicted stability, is important for full 
activity (Kollmus et al, 1996). In a third study, substitution of vector sequences for the 
entire basal stem of a GPX SECIS element abolished its ability to direct selenocysteine 
incorporation (Shen et al, 1995). Together, these observations suggest that; a) at least 
some base-paired stem below the AUGA-UGA region is important for SECIS activity, 
b) the sequence of the basal stem is not critical, and c) in some SECIS elements, increased 
length (rather than stability) of the basal stem enhances SECIS function. 
One feature distinguishes from II SECIS elements (type 3 iodothyronine 
deiodinase, phospholipid hydroperoxide GPX, plasma GPX, and the first selenoprotein 
P SECTS elements) from form I elements: the unpaired AAA nucleotides do not lie in the 
apical loop but instead form a bulge in the 5' arm (Figure 2-2A); this bulge is separated 
from the apical loop by a predicted stem of three to five base pairs (Low and Berry, 
1996). A
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The putative selenoprotein W SECIS elements belong to the form II group. All 
six selenoprotein W SECIS elements contained an AUGA in the 5' arm of the stem, 
separated by 12 bases from an unpaired AAA predicted to form a bulge in this arm of the 
stem. A 3-bp predicted stem, which was identical in all  selenoprotein W SECIS 
elements, separated the unpaired AAA nucleotides from the apical loop. The sequence 
of the apical loop in selenoprotein W SECIS elements varied considerably, even between 
closely-related species.  In other vertebrate SECIS elements, the conserved GA 
dinucleotide is not predicted to form Watson-Crick base pairs with the 5' arm of the stem 
(Low and Berry, 1995; Berry et al, 1993; Hill et al, 1993; and Walczak et al, 1996); 
however, the RNA Fold program predicted that these bases pairs with a complementary 
sequence in the 5' arm (figure 2-3). These putative 2 or 3-bp stems were flanked on both 
sides by unpaired bases, so the stability of this predicted pairs region may be low; instead, 
these bases may participate in one of the proposed non-Watson-Crick pairing schemes 
(figure 2-2B; Walczak et al, 1996). 
Comparison of selenoprotein W SECIS elements 
Predicted secondary structures for the six selenoprotein W SECIS elements were 
very similar (figure 2-3). The majority (645) of base changes in these SECIS elements 
did not disrupt putative base-paired stems (table 2-1).  Approximately 40% of the 
sequence variation occurred in unpaired regions. Eight single base changes in predicted 
stems converted GU to GC pairs and should not affect the SCEIC structure. We also 
noted seven instances in which both members of a base pair within a predicted stem 51 
Table 2-1. Comparisons of selenoprotein W SECIS elements 
Species  Bases different  Both unpaired  Both paired  Disrupt pair  GC-GU 
human/monkey  4  1  2  1  0 
human/sheep  23  9  4  10  2 
human/rat  53  21  14  18  4 
rat/mouse  10  5  2  3  2 
total  90  36 (40%)  22 (24%)  32 (36%)  8 
The species column lists the pairwise sequence comparisons. Bases different indicates the 
number of base changes between a pair of aligned SECIS elements. A base that occupies 
a loop in both SECIS elements is listed in the both unpaired column, and a base found 
within a predicted stem in both is listed as both paired; combined, these categories 
constitute the 64% of base changes that do not disrupt putative base-paired stems. A 
base predicted to occur within a stem in one SECIS sequence and unpaired in another is 
listed in the disrupt pair column. Mutations that convert GC to GU pairs or GU to GC 
pairs appear in the GC-GU column. 
differed between species such that pairing was maintained. For example, a GC pair 
between bases 349 and 469 in the human SECIS element was a CG pair in the monkey 
(figure 2-3). Thus, although the 5' arm of the monkey SECIS element contained a G to 
C transversion, a compensatory C to G mutation occurred at the proper position in the 
3' arm to maintain pairing. Covariation to maintain base pairing within a stem supports 
the validity of the computer-generated secondary structures. 
The nucleotide sequence of the stem that separates the AUGA motif from the 
AAA bulge was very highly conserved in all selenoprotein W SECIS elements (figure 2­52 
3). The first ten base pairs were identical in all cases, expect for two single base changes 
that did not disrupt pairing: a consensus GU pair was a GC pair in sheep and a consensus 
GC pair was a GU in the rat. One sheep and both rodent SECIS alleles also had an 
eleventh base pair (AU) at the bottom end of the stem, whereas the other sheep allele and 
both primate sequences had a mismatch (AC) at that position (figure 2-3). The extremely 
faithful sequence conservation suggests that this stem is critical for SECIS function. As 
in other SECIS elements, the bases immediately below the AUGA-GA region in all 
selenoprotein W SECIS elements were unpaired (figure 2-3). Potential stems, interrupted 
by bulges, may form farther below the AUGA-GA region in all selenoprotein W SECIS 
elements; however, sequence conservation in this region was low. Base changes that 
disrupt pairing occurred frequently in this region; thus, stem structures in the lower 
portion of these SECIS elements varied considerably, even between rat and mouse 
(figure2-3). This lack of preservation of both primary sequence and predicted secondary 
structure suggests that neither are important for selenoprotein W SECIS function. 
Additional conserved stem may prevent selenocysteine insertion at UGA stop 
codons 
Sequence conservation among the six selenoprotein W SECIS elements was high 
at the end of the element farthest from the apical loop. The primate SECIS elements 
contained an 8-bp stem that began (in the 5' arm) 40 bases 5' of the conserved AUGA 
(figure 2-3). Both sheep SECIS elements contained these same eight base pairs as part 
of a 15-bp stem, whereas the rodent SECTS elements contained a 6-bp stem (figure 2-3). 53 
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Figure 2-3. Selenoprotein W SECIS elements. Bold type highlights the AUGA, AAA, 
and UGA SECTS motifs. Numbers refer to nucleotide positions in the human, sheep, and 
rat cDNAs. Bases enclosed in parentheses are those where the monkey sequence differs 
from the human or the mouse sequence differs from the rat. Underlined bases indicate 
nucleotides in the sheep or rodent SECIS element that differ from the human sequence. 
indicates deletion of one base. The GCG program RNA Fold was used to predict the 
primate SECIS structures; the sheep and rodent structures were derived from the primate 
structures by making the appropriate base substitutions. The free energy of the predicted 
primate SECIS structure was -55.9 Kcal. 54 
Five of the base pairs in these stems were identical in all six SECIS sequences. Thus, 
sequence conservation in this portion of the selenoprotein W SECIS elements was 
extremely high, equal to that of the highly-conserved stem between the unpaired AAA and 
AUGA motifs. The strong conservation of these stems implies that they may play an 
important role in selenoprotein W mRNA function, although other work indicates that 
sequences 5' of the conserved AUGA (in a deiodinase SECIS) are not necessary for 
incorporation of selenocysteine into protein (Martin et al, 1996). Instead, these stems, 
which end 6-10 bases from the stop codons in each selenoprotein mRNA, may prevent 
misinterpretation of the UGA stop codons in the rodent and sheep mRNAs. 
The distance between a SECIS element and a UGA codon determines whether the 
UGA is read as a termination or a selenocysteine codon. In deiodinase mRNA, a UGA 
111 bases from the SECIS element can be read as a selenocysteine, but a UGA separated 
from a SECIS element by 51 bases is read only as a stop (Martin et al, 1996). In the 
rodent selenoprotein W mRNAs, 55 bases separated the UGA termination codon from 
the minimal SECIS element. In the sheep mRNAs, 57 bases lie between the minimal 
SECIS element and the UGA termination codon.  Aside from the rodent and sheep 
selenoprotein W mRNAs, Schistosoma GPX is the only other mRNA known to use UGA 
codons to specify both selenocysteine and termination (Roche et al, 1994); the SECIS 
element in this mRNA lies close to the UGA termination codon. The rodent and sheep 
selenoprotein W minimal SECIS elements may lie far enough from the UGA stop codons 
to prevent inappropriate incorporation of selenocysteine. We propose that the highly 
conserved stems, predicted to begin six bases from the rodent UGA codons as 55 
selenocysteine by increasing their proximity to SECIS-associated mRNA secondary 
structure.  This additional stem could not affect proper reading of the genuine 
selenocysteine codons, which lie 5' of the stem by 234 bases in the rodent and 235 bases 
in the sheep mRNAs. Thus, the selenoprotein W SECIS elements appear to have retained 
an ancillary stem that may prevent inappropriate incorporation of selenocysteine at UGA 
termination codons. 
Rat selenoprotein W SECIS is active 
Function of the rat selenoprotein W SECIS element has been demonstrated in two 
ways. First, the rat selenoprotein W SECIS element, when fused to the deiodinase coding 
sequence in place of the native deiodinase SECIS, directs incorporation of selenocysteine 
in this selenoenzyme (Berry et al, unpublished results). Second, peptide sequence analysis 
of rat muscle selenoprotein W, reported elsewhere (Vendeland et al, 1995), demonstrated 
that the rat selenoprotein W SECIS element directs incorporation of selenocysteine at 
codon 13 (UGA), as expected. This protein analysis showed that mature rat muscle 
selenoprotein W contains 87 amino acids, because the amino-terminal methionine is 
removed from the mature protein (Vendeland et al, 1995). Thus, the rat selenoprotein 
W SECIS element does not allow the translational machinery to incorporate 
selenocysteine when it reaches the UGA termination codon at position 89. 
Selenoprotein W amino acid sequences 
Figure 2-4 shows amino acid sequences deduced from the selenoprotein W 
cDNAs. The two primate sequences were identical, as were the two rodent sequences. 56 
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Primate  MALAVRVVYC GAUGYKSKYL QLKKKLEDEF PGRLDICGEG T FQATGFFEV 
Rodent  P  E H C  V 
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Primate  MVAGKLIHSK KKGDGYVDTE SKFLKLVAAI KAALAQG* 
Rodent  T V R  R T  CQ* 
Sheep  F V G  A* 
Figure 2-4.  Selenoprotein W deduced protein sequences.  The complete primate 
sequence is shown; the U (bold type) at position 13 represents selenocysteine. * indicates 
a termination codon (UAA in the primate cDNAs and UGA in the other species). For the 
rodent and sheep proteins, only the amino acid residues that differ from the primate 
sequence are shown. The rat selenoprotein W amino acid sequence was deduced from 
the cDNA nucleotide sequence and from direct peptide sequence analysis. Sequences for 
the other species are deduced from the cDNA nucleotide sequence. 
The primate and sheep proteins were one amino acid shorter than rodent proteins. Only 
15 of 88 (17) of the amino acids showed differences between species, and six of these 
changes are conservative; arginine instead of lysine, alanine in place of glycine, and valine 
substituted for leucine, isoleucine, or alanine (figure 2-4). The selenocysteine residue, at 
position 13, and the cysteine residues at position 10 and 37, were retained in the proteins 
from all five species. These selenhyfryl and sulfhydryl residues may be essential for either 
catalysis or maintenance of tertiary structure. In contrast, the cysteine residues at position 
33 and 87 of the rodent proteins were not retained in the primate or sheep proteins; these 
nonconserved residues are probably not important for selenoprotein W function. 57 
CONCLUSIONS 
1.  Selenoprotein W coding sequences are highly conserved (86.5% to 98.5% 
identical) among the five species studied.  Seventy-three (83%) of the amino acids in 
selenoprotein W are invariant in all five species, including the selenocysteine residue at 
position 13 and the cysteine residues at positions 10 and 37. The sheep and rodent gene 
use UGA as both stop and selenocysteine codons, whereas the primate coding sequences 
terminate with UAA. 
2. The SECIS elements found in the 3' untranslated regions of the six 
selenoprotein W cDNAs contain features common to other form II SECIS elements. 
Covariation of paired bases in putative SECIS stems supports the predicted secondary 
structures. 
3.  An additional highly-conserved base-paired stem, which lies outside the 
minimal SECIS element, may prevent inappropriate selenocysteine incorporation at the 
UGA stop codons in sheep and rodent selenoprotein W mRNAs. 
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ABSTRACT 
The human selenoprotein W coding region with the selenocysteine codon (TGA) 
changed to a cysteine codon (TGT) was fused to six histidine codons (at its 3' end), 
cloned into a prokaryotic expression vector (pTrc99a), and the corresponding mutated 
selenoprotein W was expressed by bacteria. The protein was purified with a Ni-NTA 
agarose column and by reverse phase HPLC. Polyclonal antibodies raised from this 
protein were used in Western blot to determine tissue distribution of selenoprotein W 
from rhesus monkeys fed a commercial chow. Selenoprotein W was found in many tissues 
with highest in the muscle and heart (6 fold greater than liver) and lowest in the liver, but 
selenium concentrations were highest in the kidney (10 fold greater than muscle) and 
lowest in the skeletal muscle. Northern blots using human selenoprotein W cDNA probe 
indicated that mRNA levels were highest in the monkey muscle and heart (2 to 2.5 fold 
greater than in liver), which is similar to the pattern found with a human multiple tissue 
Northern blot. Thus, selenoprotein W appears to be highest in skeletal muscle and heart 
in primates. The levels of selenoprotein W and mRNA in muscle and heart were also 
found to be higher in female than in male monkeys but the only statistically significant 
difference was in the selenoprotein W levels in muscle, but the selenium concentrations 
were not significantly difference. 63 
INTRODUCTION 
Selenium, a unique essential element, exhibits its biological functions in mammals 
by incorporation of selenocysteine into various selenoproteins. Selenium functions as an 
antioxidant  by  incorporation  of selenocysteine  in  the  glutathione  peroxidase 
selenoenzymes (Rotruck et al, 1973; Takahashi et al, 1987; Urisini et al, 1985; Chu et al, 
1993). Selenium also influences thyroid hormone metabolism through incorporation of 
selenocysteine in the selenoenzyme, iodothyronine 5'-deiodinase selenoenzymes (Arthur 
and Beckett, 1994), including type I 5'-deiodinase (Berry et al, 1991), type II 5'­
deiodinase (Davey et al, 1995), and type III 5'-deiodinase (Wang et al, 1993; Croteau et 
al, 1995). All these selenoenzymes contain a single selenocysteine residue located at their 
active sites. The replacement of selenium with sulfur dramatically reduces their activities 
(Berry et al 1991; Rocher et al, 1992). Selenium is incorporated into selenoprotein P as 
selenocysteine at multiple positions.  Selenoprotein P is considered to be a major 
participant in selenium metabolism (Read et al, 1990; Hill et al, 1993) and has been 
proposed to be a selenium transport protein (Motsenbocker and Tappet, 1982), or an anti­
oxidant (Burk et al, 1994).  Selenium is believed to be involved in normal muscle 
metabolism in some species by incorporation of selenocysteine into a low molecular 
weight protein (Pedersen et al, 1972) now named selenoprotein W (Vendeland et al, 
1993). Dietary inorganic selenium is converted to organic form by metabolism via HSe" 
which serves as selenium donors for conversion of seryl-tRNA to selenocysteyl-tRNA 
through selenophosphate in selenoprotein biosynthesis (Lee et al, 1996). Both organic 64 
and inorganic forms of selenium will support the dietary requirement for the mineral. 
Selenoprotein W was first purified and characterized from rat skeletal muscle 
(Vendeland et al, 1993; 1995). Like selenoprotein P, the function of selenoprotein W is 
not clear. The fact that it binds to glutathione led to speculation it has an anti-oxidant 
function similar to other selenoproteins (Beilstein et al, 1996). Furthermore, its tissue-
specific distribution implies that selenoprotein W could be involved in muscle metabolism. 
Tissue levels of selenoprotein W and/or its mRNA are clearly responsive to nutritional 
selenium intake in rats and sheep (Yeh et al, 1995; 1997). Until now no method was 
available for determination of selenoprotein W in primate tissues. Antibodies to a peptide 
based on the rodent selenoprotein W were useful in recognizing the protein in tissues of 
rat, guinea pig, sheep and cattle, but not in human or rhesus monkey tissues. 
Unfortunately, antibodies raised to a peptide based on the primate selenoprotein W failed 
to detect selenoprotein W in primate tissue because of low affinity (see appendix 2). 
Therefore, this was the focus of the present study to develop an assay for primate tissues. 
Studies of selenoprotein W gene expression in primate tissues were conducted by 
Northern blot using human selenoprotein W cDNA probe and by Western blots using 
polyclonal antibodies raised against bacterially expressed mutant human selenoprotein W. 
It was also hoped that insight into the biochemical and physiological function of this 
protein would be obtained. 65 
MATERIALS AND METHODS 
Bacterial expression and purification of mutant selenoprotein W 
A mutant form of the human selenoprotein W cDNA was prepared by PCR with 
primers that incorporated the mutation.  The sense strand PCR primer matched the 
sequence of the first 15 codons of the cDNA with a mutation in the 13th coding position 
converting a selenocysteine codon (TGA) to a cysteine codon (TGT). This primer also 
incorporated an Nco 1 restriction site near the 5' end to facilitate ligation of the PCR 
product into the expression vector. The antisense PCR primer matched the terminal seven 
codons of the cDNA open reading frame with insertion of six histidine codons prior to the 
termination codon, and included a BamHl restriction site to facilitate ligation with the 
vector. The primers were used in PCR with the cloned human selenoprotein W cDNA 
as template. The PCR product and vector pTrc99a were cleaved with the restriction 
enzymes Ncol and BamHl. The ligation product of the digests was used to transform 
TG1 host bacteria. Transformants were screened for correct insert size by restriction 
analysis and selected clones were sequenced with vector primers to verify the junctions. 
The recombinant plasmid was recovered from an expanded clone and used to transform 
BL21DE pLyss bacteria for expression of the recombinant protein. 
Large-scale expression cultures were induced with 0.1 mM IPTG for 3 hr. The 
harvested cells were resuspended in 100 mM Tris (pH 7.4) and lysed by freezing at -20° 
C. Thawed lysate was gently mixed for 30 minutes after addition of DNase (10 U/mL); 
MgCl2 (10 mM); NaCI (15 mM); phenylmethylsulfonylfluoride (1 [ig/mL); Triton X-100 
(0.1%). The lysate was centrifuged at 10,000 x g for 30 min. The supernatant was 66 
applied to a Ni-NTA agarose column. The column was washed extensively with 15 mM 
imidazole in phosphate buffer saline. The recombinant protein was eluted with a 40 mL 
gradient of 15 to 500 mM imidazole buffer.  Protein in eluate was pooled and 
concentrated to less than 0.25 ml with an Amicon Centricon-3 centrifugal ultrafiltration 
concentrator. The concentrates were chromatographed on a C-18 reverse phase HPLC 
column (The Separations Group, Hesperia, CA) with a gradient from 30 to 60% 
acetonitrile in water containing 0.1% trifluoroacetic acid at a flow rate of 1 ml/min. 
Eluate from the HPLC was collected in 0.5 mL (0.5 min) fractions. Purity of protein in 
individual fractions was checked by PAGE and Coomassie blue staining. 
Generation and purification of polyclonal antibody 
Rabbits were immunized for 9 weeks at 3-week intervals with mutant human 
selenoprotein W conjugated to KLH in Freund's adjuvant (200 pg protein/each time). 
Blood was collected by cardiac puncture at 1, 2 and 3 weeks after the last injection and 
the serum was stored frozen. The antibody was purified on an affinity column prepared 
from the bacterially expressed mutant human selenoprotein W bound to Sulfolink 
coupling gel (Pierce, Rockford, IL). After washing with 1 M NaCI and equilibration with 
PBS, rabbit sera were applied to the column. The column was washed with 6 column 
volumes of PBS and the antibody eluted with 0.1 M glycine (pH 2.8). The eluate was 
collected in 0.5 mL fractions were neutralized by adding 50 µL1 M Tris (pH 9.5). The 
antibody-containing fractions were detected by absorbance at 280 nm, desalted and 
changed to PBS buffer on a desalting column. 67 
Western blot analysis 
Rhesus monkey issues were homogenized in 5 volumes of homogenizing buffer 
containing 20 mM Tris (pH 7.5), 0.25 M sucrose, 1 mM EGTA, 5 mM EDTA, 1 mM 
PMSF, 50 mM 2-mercaptoethanol and 25 1..tg/m1 leupeptin. The homogenates were 
centrifuged at 14,000 x g for 10 min at 4°C.  Protein content was measured in the 
supernatant by the Lowry Method (Lowry et al, 1951) with bovine serum albumin as 
standards. Samples (200 [ig total protein) were electrophoretically separated on SDS­
polyacrylamide gel with 7.5 to 15 % gradient and transferred onto nitrocellulose 
membranes (0.2 !im, BA-S83; Schleicher & Schuell, Keene, NH) overnight at 4°C. The 
membranes were incubated with 5% non fat milk in TTBS (50 mM Tris-HCI, pH 7.5, 0.5 
M NaCI, 0.05% Tween-20) for 1 hour, then incubated with purified antibody (1:500 in 
TTBS containing 1% non fat milk) for 1.5 hours. After washing with TTBS, membranes 
were incubated with horse-radish peroxidase-conjugated goat anti-rabbit IgG antibody 
(1:2000 in TTBS containing 1% non fat milk). After washing with TTBS to eliminate 
excess secondary antibody, selenoprotein W signals on the membranes were detected by 
the ECL detection system (Amersham, Arlington, IL). Developed films were scanned with 
a Personal Densitometer SI and analyzed by the ImageQuaNT program (Molecular 
Dynamics, Sunnyvale, CA). Development of a human multiple tissues blot (Clontech 
Laboratories, Inc., Palo Alto, CA) was performed with the same reagents. 68 
RNA extraction and Northern blot 
The tissues from rhesus monkeys fed commercial monkey chow were obtained 
from the primate center (Beaverton, OR). Total cellular RNA was isolated by the single 
step guanidine isothiocyanate procedure (Chomczynski and Sacchi 1987). The final RNA 
pellet was dissolved in DEPC (diethyl pyrocarbonate) H2O and its concentration was 
determined spectrophotometrically at 260 nm. The ratio of 260 nm/280 nm was used to 
monitor the quality of RNA purification. Samples of 20 lig of formaldehyde denatured 
RNA were size fractioned by electrophoresis on a 1.5% agarose-2.2 M formaldehyde gel, 
and the RNA blotted onto nylon membrane (GeneScreen Plus, DuPont/NEN) in 10xSSC 
(1.5 M sodium chloride, 0.15 M sodium citrate, pH 7.0) transfer medium. Membranes 
were prehybridized at 65°C for 4 hours in a hybridization solution containing 5x SSPE, 
0.5% (W/V) SDS, 2 xDenhard's solution and 100 mg/mL of salmon sperm DNA. 
Hybridization of cDNA probe was performed at 65°C for overnight in the hybridization 
solution with 30 ng/mL of dig-dUTP labeled probe. After hybridization, the membranes 
were washed 2x30 min at room temperature with wash solution (2xSSC, 0.1% SDS) 
and then 2x30 min at 65°C with wash solution 2 (0.1x SSC, 0.1% SDS) to remove excess 
probe and non-specific binding.  The hybridized RNA signals were detected by 
chemiluminesce detection system based on the procedure described by Krueger (1995). 
Probe was removed by incubation blot in boiled 0.5% SDS solution for 10 min 
with frequent shaking and then incubated in 2xSSC solution for 5 min at room 
temperature. Hybridization and washing were conducted under the same conditions 
except the temperature was decreased to 45°C when the oligonucleotide ribosome probes 69 
were used to reprobe the samples. The relative intensities of the hybridization signals were 
determined by scanning densitometry (Molecular Dynamics, Sunnyvale, CA) and analyzed 
by the Image-QuaNT program (Molecular Dynamics, Sunnyvale, CA). The level of 
selenoprotein W mRNA in each well of cells was expressed as selenoprotein W 
mRNA/18s rRNA ratios.  Northern blot for human multiple tissues (Clontech 
Laboratories, Inc., Palo Alto, CA) was performed by the same conditions described 
above, but only prehybridization and hybridization were performed at 65° C for 1 hour 
respectively in an ExpressHyb solution (Clontech Laboratories, Inc., Palo Alto, CA) with 
selenoprotein W cDNA probe or 13-actin probe. 
Digoxigenin nuclei acid labeling 
Selenoprotein W probe and  13-actin probe were prepared by PCR from human 
selenoprotein W cDNA in Maxl vector and human 13-actin cDNA in pBR 322 vector 
respectively. Primers were designed based on the selenoprotein W cDNA coding region, 
and the 13-actin 3' untranslated region which is specific for p -actin and does not cross 
react with a-actin or y-actin. Digoxigenin-labeled dUTP (Boehringer Mannheim 
Biochemica, Indianapolis, IN) was incorporated into DNA probes by PCR amplification 
under standard conditions. The PCR products were purified by Chroma Spin' Columns 
(Clontech Laboratories, Inc., Palo Alto, CA) and the probe concentrations estimated by 
electrophoresis in comparison to DNA mass ladders. 
A universal 15 bases oligonucleotide probe for a small subunit of the 18s 
ribosomal RNA was used as an internal standard. This short oligonucleotide (1406R) 70 
(Lane at al, 1985) with a sequence of ACGGGCGGTGTGTRC was the kind gift of Dr. 
Stephen Giovannon,  Department  of Microbiology,  Oregon  State  University. 
Oligonucleotide was enzymatically labeled with terminal transferase by incorporation of 
a single digoxigenin-labeled dUTP using standard conditions (Boehringer Mannheim 
Biochemica, Indianapolis, IN). The labeling efficiency and probe concentrations were 
estimated by anti-digoxigenin immunological detection in comparison with standard. 
Glutathione peroxidase activity and selenium content 
cGPX activity was measured by coupled enzyme method using  hydrogen 
peroxide as a substrate  (Paglia and Valentine,  1967) with a DU Series 60 
spectrophotometer. After digestion of the tissues with nitric and perchloric acids, the 
selenium concentration was determined by the semiautomated fluorimetric method 
(Brown and Watkinson, 1977). 
Statistical analysis 
Data were examined for equal variance and normal distribution prior to statistical 
analysis. Mean values were compared by analysis of variance (ANOVA) with Fisher's 
least-significant difference (LSD) method (Steel and Torrie, 1980). 71 
RESULTS 
Construction of plasmid and purification of expressed protein by E. con 
The prokaryotic expression vector pTrc-H was constructed (figure 3-1) and 
verified by Nco 1 and BamHl restriction enzyme digestion.  The recombinant DNA 
contained human selenoprotein W coding region where selenocysteine codon TGA was 
replaced with cysteine codon TGT and 6 histidine codons were added at the c-terminal 
end. Two different restriction enzymes allowed for the insertion in a sense orientation and 
the start codon ATG located down stream of the pTrc promoter. The mutant 
selenoprotein W was purified on a Ni-NTA from bacterial lysate. As shown in figure 3­
2A, purification by Ni-NTA agarose columns yielded a recombinant protein which was 
approximately 50% pure. Fractions 15-20 was pooled, dialyzed, concentrated and 
chromatographed on reverse phase HPLC columns. The relatively pure recombinant 
protein was eluted in fractions 47-49 as shown by a signal band in Commassie blue stained 
gel (figure 3-2B).  The identity of the purified protein was confirmed by mass 
spectrometry and partial N-terminal amino acid sequence. 
Testing antibodies generated against bacterially expressed selenoprotein W 
As shown in figure 3-3A, a Western blot of monkey tissues developed with 
antibodies against bacterially expressed mutant human selenoprotein W produced a signal 
at a molecular mass between 6 KDa and 14 KDa. The antibody binding was proven to 
be specific for selenoprotein W by preincubating the antibody with pure selenoprotein W 
in which the selenoprotein W signals were completely eliminated (figure 3-3B) 72 
6 x his--stop codon--BamH Human Selenoprotein W Nco I--start codon 
Figure 3-1. Plasmid map of pTrc-HSW. Mutant human selenoprotein W cDNA coding 
region (the selenocysteine codon TGA was replaced with cysteine codon TGT, and 6 
histidine codons were added at c-terminal) was inserted between the Nco 1 and BamH 
sites of pTrc 99a vector.  This is a prokaryotic expression vector with a strong 
promoter (trc) upstream and a strong transcription termination signal (rrnB) downstream. 
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Figure 3-2. SDS-PAGE gels to follow the purity of mutant human selenoprotein W. A. 
The first step purification by Ni-NTA agarose column. The target protein was eluted with 
15-500 mM imidazole gradient and examined by electrophoresis.  Lane 1, molecular 
weight markers, ovalbumin (MW 46000), carbonic anhydrase (MW 30000), trypsin 
inhibitor (MW 21500), lysozyme (MW 14300), aprotinin (MW 6500), insulin b chain 
(MW 3400) and insulin a chain (MW 2350).  Lanes 2-10, fractions 12-20. B. 
Chromatography of pooled Ni-NTA eluant fractions on a HiPLC reverse phase column. 
A gradient of 30-60% acetonitrile in water with 0.1% trifluoroactic acid was used over 
30 minutes at a flow rate of 1 ml/min. Eluates were collected in 0.5 min (0.5 mL) and 
subjected to electrophoresis. Lane 1, molecular weight markers as above. Lanes 2-10, 
fractions 42-50. 74 
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Figure 3-3. Western blot analysis of selenoprotein W in monkey tissues. A. Polyclonal 
antibodies against bacterially expressed mutant human selenoprotein W. Lanes 1-6, 200 
1.ig of cytosol protein samples from muscle, heart, brain, spleen, kidney and liver, 
respectively. Lane 7, 10 ng of pure mutant human selenoprotein W. The positions of 
molecular weight markers were shown at the left side. B. The same procedures used in 
(A) but with antibodies pre-incubated with mutant human selenoprotein W before 
developing the membrane. 75 
Selenium, GPX and selenoprotein W distribution in monkey tissues 
Examination of selenoprotein W distribution in monkey indicated its levels varied 
between tissues. Using densitometer readings and a standard curve derived from purified 
selenoprotein W from monkey skeletal muscle (see chapter 4), the mean concentrations 
of selenoprotein W ranged from 20 ng/mg protein in liver to 120 ng/mg protein in muscle 
(figure 3-4A). The levels of selenoprotein W were similar in tongue, heart and brain. 
Tissues concentration of selenium and GPX activity did not follow the pattern as 
selenoprotein W. GPX activity was highest in liver and lowest in muscle (figure 3-4B) 
but selenium concentration was highest in kidney and lowest in muscle (figure 3-4C). 
Selenoprotein W levels in skeletal muscle and heart cytosol were compared 
between male and female monkeys. The intensities of the selenoprotein W signals were 
greater in samples from female than from male monkey (figure 3-5A).  The mean 
concentration of selenoprotein W was significantly higher (p<0.05) in muscle of female 
monkeys (figure 3-5B), but there was no different in selenium levels between gender (data 
not shown). 
Selenoprotein W mRNA 
Northern blot analyses of monkey tissue total RNA are shown in figure 3-6A. The 
intensities of the signal with selenoprotein W cDNA probe were greatest for muscle, heart 
and brain, and lowest for liver. The ratio of selenoprotein W to 18s-rRNA was used to 
correct for the variation in sample loading for each tissue RNA sample. The pattern of 
mRNA levels of selenoprotein W (figure 3-6B) showed the same distribution pattern as 76 
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Figure 3-4. Selenium contents, GPX activities and selenoprotein W levels in monkey 
tissues. Error bars indicate standard errors of the means of tissues from 2 male and 2 
female animals except testis and ovary (n=3). Different superscripts in each bar graph 
represent significant difference (p<0.05). A: Selenoprotein W levels (ng/mg protein). B: 
Selenium concentrations (pg/g dry weight of tissue). C: GPX activities (n mole NADPH 
oxidized/min/mg protein). 77 
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Figure 3-5. Levels of selenoprotein W in male and female monkeys. A: Western blot of 
selenoprotein W in monkey tissues.  Lanes 1-3: 20 ng, 10 ng and 5 ng of purified 
selenoprotein W from monkey muscle, Lanes 4-6: muscle samples from males, lanes 7-9: 
muscle samples from females, lanes 10-12: heart samples from males, and lanes 13-15: 
heart samples from females. B: Bar graph analysis depicting the selenoprotein W content 
calculated from a standard curve of purified monkey selenoprotein W. Error bars indicate 
standard errors of the means (n=3). Different superscripts represent significant differences 
(p<0.05). 78 
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Figure 3-6. Selenoprotein W mRNA in monkey tissues. A: A typical set of Northern blots 
of selenoprotein W in monkey tissues. Total RNA was isolated from monkey tissues and 
analyzed by Northern hybridization first with selenoprotein W cDNA probe and then with 
18s-rRNA oligomer probe. Lane 1-2: muscle, lane 3: tongue, lane 4: heart, lane 5-6; 
brain, lane 7: spleen, lane 8: kidney, lane 9: liver and lane 10: ovary. B: Bar graphs depict 
the selenoprotein W mRNA levels standardized to 18s-rRNA to correct for loading 
variations.  Error bars indicate standard errors of the means of 2 male and 2 female 
monkeys for all tissues except testis and ovary (n=3). 79 
selenoprotein W protein levels (figure 3-4A) in monkey tissues.  The ratios of 
selenoprotein W mRNA tol8s-rRNA in muscle and heart were 3 fold greater than in liver. 
However, this difference between tissues in mRNA levels (3 fold) is less than that in 
protein levels (6 fold). 
The total RNAs from skeletal muscle and heart from female and male monkeys 
fed a commercial chow were subjected to Northern blot analyses as shown in figure 3-7A. 
The intensities of selenoprotein W mRNA signals were greater in female animals than in 
the males. The ratios of mRNA hybridization of probes for selenoprotein W and 18s­
rRNA were determined. The normalized mRNA levels in the female samples were slightly 
higher than in males in both muscle and heart, but the differences were not statistically 
significant (figure 3-7B). 
Northern analysis of preblotted human multiple tissues poly (A+) RNA membrane 
(purchased from Clontech) is shown in figure 3-8A. Selenoprotein W was expressed in 
all tissues examined with an estimated size of 820 bases, while the highest mRNA level 
was in muscle. The ratio of mRNA hybridization with probes for selenoprotein W and 
[3-actin for each lane was determined. As shown in figure 3-8 B, the selenoprotein W 
mRNA was highest in skeletal muscle and heart, and lowest in lung. The mRNA levels 
were almost 4 fold higher in muscle and heart than in most other tissues. 80 
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Figure 3-7. Selenoprotein W gene expression in male and female monkeys. A: Total RNA 
was isolated from monkey tissues and analyzed by Northern hybridization first with 
selenoprotein W cDNA probe and then with 18s-rRNA oligomer probe. Lanes 1-3: 
muscle samples from males, lanes 4-6: muscle samples from females, lanes 7-9: heart 
samples from males, and lanes 9-12: heart samples from females. B: Bar graphs depict the 
selenoprotein W mRNA levels standardized tol8s-rRNA to correct for loading variations. 
Error bars indicate standard errors of the means (n=3). Different superscripts represent 
significant difference (p<0.05). 81 
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Figure 3-8. Selenoprotein W gene expression in human tissues. A: human multiple tissue 
Northern blot purchased from Clontech contained 2 vig of poly A+ RNA per lane. The 
blot was hybridized first with selenoprotein W cDNA probe and then with p-actin probe. 
Lane 1: heart, lane 2: brain, lane 3: placenta, lane 4: lung, lane 5: liver, lane 6: skeletal 
muscle, lane 7: kidney and lane 8: pancreas . B: Bar graphs depict the selenoprotein W 
mRNA levels standardized to [3-actin to correct for loading variations. 82 
DISCUSSION 
The pTrc 99a expression vector provides high-level expression of target protein 
in bacteria. It contains a regulated promoter/operator element, consists of Trc promoter 
and Lac operator sequences.  Expression of pTrc vector is rapidly induced by the 
addition of IPTG, which inactivates the repressor and clears the promoter. By using this 
system, mg levels of target protein was obtained. Single step purification by Ni-NTA 
agarose column yielded a mixture containing almost 50% target protein (figure 3-2A). 
Chromatography on the HPLC reverse phase column produced a relatively pure target 
protein (figure 3-2B). This mutant human selenoprotein W was successfully used to 
immunize rabbits for generation of the polyclonal antibodies and to make an 
immunoaffinity column for purification of its corresponding antibodies. This procedure 
allows far more efficient production of selenoprotein W than the one used to purify it 
from animal tissues (Vendeland et al, 1993). 
Antibodies against a peptide based on rat selenoprotein W worked well in Western 
blots of rat and sheep tissues (Yeh et al, 1995; 1997). In muscle cytosol from rat, guinea 
pig, cattle and sheep, a Western blot signal with an estimated molecular weight of 10 
KDa was shown to be selenoprotein W. No signal was detected at this position in tissues 
from primates. Instead, a strong band with an estimated molecular weight 25 KDa was 
found in monkey muscle and tongue samples, and in human muscle and heart samples (see 
appendix 2).  This indicated that either anti-peptide antibody did not recognize the 
primate selenoprotein W or that the primate protein was much larger than in other 83 
species. Amino acid sequences deduced from the selenoprotein W cDNAs indicated that 
it was highly conserved among five species (Whanger et al, 1997). The cDNAs indicated 
that selenoprotein W from all five species were approximately the same size. The 
selenoprotein W peptide used to generate antibodies (Beilstein et al, 1993; Yeh et al, 
1995) is a 19-mer corresponding to the 13th to 31st amino acids. Three amino acids of 
19-mer are different from those in the primate sequence (see chapter 2). The 17th amino 
acid is proline in rodent and sheep, but serine in primates. The 23rd and 27th amino 
acids are glutamic acid and histidine respectively in rodents, but lysine and aspartic acid 
in primates and sheep. Pro line is a cyclic amino acid which can form a loop in a-helices 
and thus plays an important role in protein conformation. This difference in primate and 
rodent (and sheep) selenoprotein W is apparently enough to result in different antibody 
responses. Therefore, antibodies against rat peptide recognized the selenoprotein W from 
rat, cattle and sheep but failed to recognize monkey and human selenoprotein W. 
Antibodies against a peptide based on human selenoprotein W (13th to 31st amino 
acids) were produced. These polyclonal antibodies failed to recognize selenoprotein W 
in primate tissues but recognized relative pure protein (mutant human selenoprotein W, 
see appendix B), so they were not suitable for Western analysis. Pro line, with its side 
chain aliphatic character, can usually increase the antigenicity of a peptide. The human 
peptide contains only one proline compared to two prolines in the rat peptide. Thus, its 
corresponding polyclonal antibodies could have low affinity and not function very well 
in the Western blot with primate tissue supernatant. Use of bacterially over expressed 
proteins as the antigen has several advantages. Because of the larger size, the antigen 84 
contains more epitopes than the smaller peptide, thus there is a greater chance that the 
antibodies will bind to the protein. Western blot analysis indicated that the antibodies 
raised against bacterially expressed human selenoprotein W can recognize either pure or 
tissue cytosol selenoprotein W, and the binding was shown to be specific for 
selenoprotein W (figure 3-3). 
The selenoprotein W gene is expressed in all tissues examined in both monkey and 
human tissues but highest in the skeletal muscle and heart (figure 3-3, 3-6, 3-8). The 
levels of selenoprotein W and its mRNA in muscle and heart are higher in female than in 
male monkeys but the difference was significant only for selenoprotein W levels in muscle, 
even though the selenium concentrations were not significantly different (figure 3-5, 3-7). 
Similar patterns were noted for male and female rats (Yeh, unpublished results). 
Differences due to gender were also found for glutathione peroxidase (Prohaska and 
Sunde, 1993). It is known that women and children were more sensitive to selenium 
deficiency resulting in greater incidence of Keshan disease (Chen et al 1980). Selenium 
plays an important role in muscle metabolism but it is not known whether this function 
is manifested through selenoprotein W. Since selenoprotein W is highest in the muscle, 
it has been hypothesized to play a critical role in muscle metabolism (Yeh et al, 1995; 
1997). 
Selenoprotein W was identified and purified with respect to selenium but its 
biological function is not known. Other selenoproteins such as glutathione peroxidase and 
bacterial selenoproteins have redox functions (Stadtman et al, 1990; 1996).  It seems 
reasonable to suggest such a function for selenoprotein W, especially with the 85 
demonstration that two of four species contain glutathione (Beilstein et al, 1996). There 
are some species differences in tissue distribution of selenoprotein W between various 
animals. Selenoprotein W and its mRNA were found only in the muscle, brain, testes and 
spleen of rats (Yeh et al, 1995; 1997), but its content was as high in the heart as in the 
muscle tissues from sheep fed a diet with selenium (Yeh et al, 1997). The present studies 
indicated that selenoprotein W and its mRNA were present at highest levels in primate 
muscle and heart (figure 3-3, 3-5 and 3-8), which is similar to ovine tissues (Yeh et al, 
1997). Selenoprotein W and its mRNA were respectively 6 and 3 folds higher in skeletal 
muscle and heart than in liver. This pattern was different from that for selenium 
distribution (10 fold greater in kidney than in muscle), and GPX activities (10 fold greater 
in liver than in muscle). Even though selenium concentration and GPX activity were 
lowest in muscle, selenoprotein W levels were highest in this tissue, suggesting a priority 
for selenium in this tissue. The absence of selenoprotein W in rat heart was somewhat 
surprising, but may reflect the difference in selenium deficiency syndromes between 
species. Selenium deficiency results in cardiac damage in sheep and humans but not in 
rats.  Lesions of white muscle disease in cattle and sheep (Schubert et al, 1961) and 
Keshan disease in humans (Chen et al, 1980) are primarily calcification and degeneration 
of skeletal muscle and/or of myocardium. Calcium is a significant regulator of muscle 
cell metabolism. The ability of sarcoplasmic reticulum tubules to sequester calcium is 
reduced in selenium deficient sheep muscle (Tripp et  al,  1993). Examination of 
selenoprotein W amino acid sequences revealed a region (amino acids 61-72) which is 
highly homologous with the calcium binding domain of calmoludin (Takeda and 86 
Yamamoto, 1987). Thus selenoprotein W could be involved in muscle metabolism via 
binding of calcium. Lower levels of selenoprotein W found in selenium deficiency could 
be the cause of the resulting degeneration and calcification of cardiac and skeletal muscle. 
Further studies are needed to elucidate the metabolic function of selenoprotein W. 
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ABSTRACT 
Selenoprotein W was purified from monkey skeletal muscle for investigations of 
its properties in comparison to the rat protein which had been previously characterized. 
The purification was accomplished in three steps: Sephadex G-50 gel filtration, cation-
exchange chromatography with CM-Sephadex and reverse phase high pressure liquid 
chromatography with a C-18 Vydac column. The protein was monitored by slot blot 
during purification to identify the fractions containing selenoprotein W.  The final 
chromatographic separation resulted an electrophoretically pure selenoprotein W 
preparation with estimated molecular weight of 10 KDa. The pure protein was shown 
to be selenoprotein W by N-terminal amino acid sequencing.  Matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry (MALDI) revealed that the "pure" 
preparation contained proteins with masses of 9635±7, 9371±11 and 9330±5 Da. The 
theoretical mass of the protein predicted from the cDNA sequence is 9330 Da. The 
higher mass forms of the protein apparently result from binding of small molecular weight 
moieties. The 9635 Da form of the protein was shown to contain bound glutathione 
(GSH, 306 Da) which could be released by reduction with dithiothreitol at 50° C. The 
form with mass of 9371 Da is assumed to result from binding of an unidentified 41 Da 
moiety to the 9330 Da form of the protein.  MALDI peptide mapping with 
endoproteinase Glu-C suggested that glutathione is bound to the 36th animo acid 
(cysteine) of selenoprotein W. 92 
INTRODUCTION 
Selenium is an essential trace nutrient for animals including humans. In the late 
1950's, selenium deficiency was demonstrated to be the cause of white muscle disease 
(Schubert et al, 1961). This disease was characterized by calcification and degeneration 
of skeletal muscle and sometimes involved the cardiac muscle. Selenium deficiency was 
also found to be responsible for Keshan disease in isolated regions of China (Chen et al 
1980). Keshan disease, which afflicts especially children and multiparous women, is 
similar to white muscle disease but cardiac muscular degeneration is  its greatest 
manifestation. Selenium deficiency has also been associated with muscle weakness in 
patients receiving long-term parenteral nutrition (Brown et al, 1986). These disorders can 
be alleviated and/or prevented by selenium supplementation (Muth, 1970; Yang et al, 
1984; Van Rij et al 1981). Selenium appears to be required to maintain normal muscle 
metabolism, but its mode of action is unknown. The protective effect of selenium on 
muscle tissues may be mediated through the selenoproteins. 
Several mammalian selenoenzymes have been identified and their biological 
functions can be imputed. The selenium containing glutathione peroxidases protect from 
toxicity of activated oxygen species by converting peroxides to alcohols (Rotruck et al, 
1973; Ursini et al, 1985; Takahashi et al, 1987; Chu et al, 1993). These selenoenzymes 
contain one selenocysteine per subunit at their active sites. Iodothyronine 5' deiodinases 
convert the thyroid hormone, T4 to its biologically active form, T3 (Berry et al, 1991; 
Davey et al, 1995). These selenoenzymes also contain a single selenocysteine at their 93 
active sites. The only known selenoprotein containing multiple selenocysteine residues 
is selenoprotein P (Read et al, 1990; Hill et al, 1991). This protein was suggested to 
function as a selenium transport protein because of its extracellular location and 
abundance of selenocysteines.  It may also function as an antioxidant (Burk and Hill, 
1994). Selenoprotein W, another selenoprotein, was originally identified by its failure to 
incorporate isotope labeled selenium in muscle and heart of lambs suffering from selenium 
deficiency myopathy (Pedersen et a1,1972). Recently, this protein was purified and its 
cDNA was cloned from rat skeletal muscle (Vendeland et al, 1993; 1995). Western blot 
analysis indicated that selenoprotein W occurred at high levels in muscle tissues from rat, 
sheep and monkeys (Yeh et al, 1995; 1997; and see chapter 3).  The occurrence of 
selenoprotein W in normal muscle at high levels compared to other tissues suggests that 
the biological function of selenium in maintaining healthy muscle may be mediated 
through this protein. 
At present, the largest portion of information about selenoprotein W was obtained 
from studies with rats, and less is known about this protein in other animals. Selenium 
deficiency myopathy does not occur in rats but it does occur in sheep and humans. 
Deduced amino acid sequences from the selenoprotein W cDNAs of five species 
possessed 83% identity (Whanger et al, 1997; and Gu et al, 1997). The two primate 
(human and rhesus monkey) sequences were identical, as were the two rodent (rat and 
mouse) sequences. Although no selenium deficiency syndrome has been identified in the 
rhesus monkey, information about selenoprotein W obtained from the monkey may be 
useful for understanding the function of the protein in human muscle because of the close 94 
genetic relationship and the identity of the selenoprotein W peptide sequence for the two 
species. 
Two of the four forms of selenoprotein W isolated from rat muscle were found 
to contain bound glutathione (GSH) (Beilstein et al, 1996).  The binding of small 
molecules to selenoprotein W had not been examined in any other species prior to this 
study.  The goal of this study was to purify and characterize selenoprotein W from 
monkey skeletal muscle and to obtain information on binding of glutathione. 
Demonstration of glutathione binding in selenoprotein W isolated from muscle of another 
species would indicate whether this feature of the selenoprotein is generalizable beyond 
the rat.  Selenoprotein W from rats and mice contains four cysteine residues but the 
primate selenoprotein contains only two cysteine residues (Whanger et al, 1997; Gu et al, 
1997). Since the primate protein has fewer candidate glutathione binding sites, it was 
easier to identify the binding site in the primate selenoprotein W through peptide mapping 
studies. 
MATERIALS AND METHODS 
Materials 
Monkey skeletal muscle was obtained from the Oregon Regional Primate 
Research Center (Beaverton, OR).  Sephadex G-50 and the cation-exchange CM-
Sephadex were obtained from Pharmacia Biotech Inc. (Piscataway, NJ). A reverse phase 
vydac C-18 protein HPLC column was obtained from The Separation Group (Hesperia, 95 
CA). Endoproteinase Glu-C was purchased from Sigma (St. Louis, MO). Nitrocellulose 
membranes (0.2 gm BA-S83) were purchased from Schleicher & Schuell (Keene, NH). 
Horse radish peroxidase-conjugated goat anti-rabbit IgG antibody was obtained from Bio-
Rad (Richmond, CA). ECL detection system and ECL Hyperfilm were purchased from 
Amersham (Arlington Height, IL). All other chemicals and reagents were of analytical 
grade. 
Purification of selenoprotein W 
About 180 g of frozen monkey skeletal muscle was manually chopped with 
scissors in 4 volumes (w/v) 50 mM sodium phosphate buffer, pH 6.5, containing 0.1 mM 
phenylmethylsulforyl fluoride (PMSF) and 0.02% sodium azide (buffer A). The chopped 
muscle was homogenized with an Omni-mixer (Sorvall, New Bedford, CT) for 3 min at 
a maximum speed. The homogenate was centrifuged at 10,000 x g for 30 min, the 
supernatant filtered through 2 layers of cheesecloth and recentrifuged at 100,000 x g for 
90 min in an ultracentrifuge (Beckman L8-M, Palo Alto, CA).  The centrifugal 
supernatant was concentrated to 300 ml by using an Amicon cell equipped with YM 3 
ultrafiltration membranes (Amicon Corp. Danvers, MA) with slow stirring under nitrogen 
at 4°C. 
The concentrated cytosol was chromatographed on  a large Sephadex G-50 
column (5.5 x 150 cms). The column was equilibrated and eluted with buffer A. The 
column eluant was monitored for protein by 280 nm absorbance and analyzed by western 
slot for selenoprotein W. The blots were developed with rabbit polyclonal antibody 96 
against a bacterially expressed mutant form of primate selenoprotein W. A pool of low 
molecular weight immunoreactive column eluant was concentrated to 10 ml in a stirred 
cell  with an Amicon YM 3  ultrafiltration membrane.  The concentrate was 
rechromatographed on a smaller Sephadex G-50 column (2.5 x 120 cms).  The 
immunoreactive fractions were pooled to exclude significant contamination of 
cytochromes. 
The G-50 pool was adjusted to a volume of 100 ml with buffer A and 
chromatographed on a CM-Sephadex cation-exchange column (2.0 x 28 cms). The 
column was washed thoroughly with 200 ml buffer A and the selenoprotein was eluted 
with a 400 ml linear gradient of 0-0.5 M NaCI in buffer A. The immunoreactive fractions 
were pooled and concentrated to 250 1_11 using a centifugable microporous concentrator 
(Centricon-3  ,  Amicon).  This preparation was chromatographed on a reverse phase 
HPLC column (Vydac C-18, 51..tm ODS 218 TP column, 4.6 mm x 25 cms) with a 30­
60% acetonitrile gradient in water containing 0.1% trifluoroacetic acid. Protein in the 
column eluant was monitored by 230 nm absorbance. The fractionated column eluant was 
assayed by slot blot for selenoprotein W. 
Selenoprotein W assay by slot blot 
A mutant form of primate selenoprotein W was expressed in bacteria for use in 
immunizing rabbits to obtain antibodies to the selenoprotein. A previously cloned human 
selenoprotein W cDNA was replicated by PCR with primers which mutated the 
selenocysteine codon (TGA) to a cysteine codon (TGT). The PCR primers also added 97 
six histidine codons to the 3' end of the coding region to facilitate purification. The PCR 
replicated cDNA was cloned into the prokaryotic expression vector, pTrc99a (Pharmacia, 
Piscataway, NJ), for expression in E. coli. The protein was purified from bacterial lysate 
using a Ni-NTA agarose column (QIAGEN Inc., Chatsworth, CA) and by reverse phase 
HPLC. Rabbits were immunized with this protein and the resultant polyclonal antibodies 
were purified from rabbit sera on a sulfolink affinity column (Pierce, Rochfold, IL) 
coupled with the bacterially expressed selenoprotein W. These antibodies were used in 
slot blots to identify selenoprotein W during the purification. 
Slot blots were performed with a commercial apparatus (Schleicher and Schuell 
Minifold II, Keene, NH). Nitrocellulose membranes were cut to the size of the manifold 
and placed in the slot blot apparatus  Samples was loaded on the slots and allowed to . 
filter through membrane under low vacuum.  After air drying,  membranes were 
incubated with blocking solution (5% non-fat dry milk in TTBS) for 1 hr, and incubated 
with polyclonal antibodies for 1.5 hr.  After washing with TTBS, membranes were 
incubated with horse radish peroxidase-conjugated goat anti-rabbit IgG antibody. After 
washing with TTBS to eliminate excess secondary antibody, the membranes were 
incubated with ECL reagent (Amersham Life Science, Inc., Arlington Heights, IL) and 
the signal was detected by exposure of ECL Hyperfilm (Amersham Life Science, Inc.). 
Developed films were scanned with a Personal Densitometer SI (Molecular Dynamics, 
Sunnyvale, CA) and analyzed by the ImageQuaNT program (Molecular Dynamics, 
Sunnyvale, CA). 98 
Mass spectrometry assay to characterize selenoprotein W 
A custom-built time-of-flight mass spectrometer equipped with a frequency tripled 
(355 nm) Na:YAG laser of pulsed matrix-assisted laser desorption/ionization (MALDI) 
mass spectrometry (Hillenkamp et al, 1991) was used to determine the molecular weight 
of intact selenoprotein W. For examination of reduced protein, selenoprotein W was 
treated with final concentration of 10 mM dithiothreitol at 50° C for 1 hr. For peptide 
mapping, selenoprotein W was digested by endoproteinase Glu-C in phosphate buffer, 
pH 7.8, at 37° C for 18 hr and examined by MALDI-MS. The computer program 
MacBioSpec 1.0.1 (PE, SCIEX) was used to identify the proteolytic fragments detected 
by MALDI mass spectrometry. 
RESULTS 
A summary of the purification of selenoprotein W from monkey skeletal muscle 
cytosol is presented in table 4-1. The cytosol was prepared in 50 mM Na2PO4 buffer, pH 
6.5, containing the proteinase inhibitor PMSF. The purification employed an Amicon 
stirred cell ultrafiltration apparatus to concentrate the muscle cytosol and several 
chromatographic pools later in the purification.  Concentration to a small volume 
improved the separations achieved in the gel filtration purification steps. 
Results of Sephadex G-50 gel filtration of the concentrated cytosol (about 300 ml) 
is presented in figure 4-1. The main protein peak was centered at about fraction 50, but 
the main immunoreactive peak was centered at fraction 90. This peak was separated 99 
Table 4-1. Summary of steps used for the purification of selenoprotein W 
from monkey muscle. 
Step  Total protein  Protein yield (%) 
1. Homogenization  150 g  100 
2. Centrifugation  26 g  17 
3. Concentration by Amicon cell  10 g  6.7 
4. Gel filtration on G-50 Sephadex  75 mg  0.05 
5. Cation exchange on CM-Sephadex  1.4 mg  0.009 
6. HPLC chromatography on C-18 reverse phase column  120 pg  0.00008 
almost completely from the major protein peak which eliminated most of the large 
molecular weight proteins. 
Fractions 70 to100 were combined, concentrated and rechromatographed on a 
smaller Sephadex G-50 column (figure 4-2). The immunoreactive peak of selenoprotein 
W was eluted just after the 280 nm absorbance peak, which is assumed to contain 
cytochrome C because of the pink color.  Fractions 30 to 38 were combined, which 
excluded most of the slightly larger protein assumed to be cytochrome C. The combined 
fraction was chromatographed on the cation exchange column. After extensive washing, 
the protein was eluted with a gradient of 0 to 0.5 M sodium chloride (figure 4-3). The 
immunoreactive material eluted from the column in three partially separated peaks at 100 
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Figure 4-1. Gel filtration of concentrated monkey muscle cytosol.  Approximately 10 g 
total protein in 300 ml of cytosol were applied to a column (5.5 x 150 cms) of G-50 
Sephadex, equilibrated and eluted with 50 mM phosphate buffer at a flow rate of 60 ml 
per hour; 20 ml were collected per fraction. 101 
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Figure 4-2. Sephadex G-50 rechromatography from the prior gel filtration step (figure 
4-1). The fractions (70 to 100) from the prior column were pooled, concentrated and 
rechromatographed on a column (2.5 x 120 cms) with 50 mM phosphate buffer at a flow 
rate of 30 ml per hour; 5 ml were collected per fraction. 102 
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Figure 4-3. CM-Sephadex cation-exchange chromatography of the fractions which 
hybridized with antibodies from the prior gel filtration step (figure 4-2). The fractions (30 
to 38) from the prior column were pooled, diluted and chromatographed on a column 
(2.0 x 28 cms) with a 0 to 0.3 M sodium chloride gradient in 400 ml 50 mM phosphate 
buffer at a flow rate of 30 ml per hour; 5 ml were collected per fraction. 103 
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Figure 4-4. Chromatography of the fractions which hybridized with antibodies from CM-
Sephadex cation-exchange column. The fractions 10 to 17, 18 to 24 and 25 to 30 from 
the prior column (figure 4-3) were pooled and concentrated separately as C-1, C-2 and 
C-3 respectively, and chromatographed on HPLC reverse phase column ( Vydac C-18, 
5 [tm ODS 218 TP column, 4.6 mm x 25 cms). A gradient from 30-60% acetonitrile in 
water with 0.1% trifluoroactic acid was used at a flow rate of 1 ml/min over 30 minutes; 
0.5 ml was collected per fraction. A. HPLC chromatography of C-1 pool. B. HPLC 
chromatography of C-2 pool. 104 
approximately 0.06, 0.075 and 0.1 M sodium chloride. The three peaks were pooled 
separately, concentrated and called C-1, C-2 and C-3 in order of elution. 
The cation exchange pools were chromatographed on the HPLC column. As 
shown in figure 4-4, the immunoreactive protein from pool C-1 eluted as a single major 
peak at approximately 49% acetonitrile, but the C-2 pool was split into three partially 
separated peaks at approximately 49, 50 and 51% acetonitrile.  The three peaks are 
designated C-2a, C-2b and C-2c in order of elution. The HPLC chromatographic pattern 
of immunoreactive peaks from pool C-3 were the same as C-2 (data not shown). 
Silver stained SDS/PAGE gels of the protein at various stages of purification 
are shown in figure 4-5. There were multiple bands (labeled A) after Sephadex G-50 gel 
filtration,  but two major bands remained after CM-Sephadex cation exchange 
chromatography (labeled B). The last step using a reverse phase HPLC chromatography 
yielded a single band with an estimated molecular weight of 10 KDa (labeled C). 
The precise molecular weights of the different forms of protein from the HPLC 
column were determined by MALDI mass spectrometry (figure 4-6). As shown in table 
4-2, C-1 and C-2a have the same mass of 9635 ± 7 Da. This is the predominant form of 
selenoprotein W isolated from monkey muscle. Masses C-2b and C-2c were 9371±11 Da 
and 9330±5 Da respectively. The masses of C-3 were similar to C-2 (data not shown). 
The difference between the highest and lowest mass is approximately 305 Da, and the 
other form has mass 41 Da higher than the lowest one. 105 
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Figure 4-5. SDS-PAGE gel of selenoprotein W at various stages of purification. Lanes 
S, low molecular marker, ovalbumin (MW 46000), carbonic anhydrase (MW 30000), 
trypsin inhibitor (MW 21500), lysozyme (MW 14300), aprotinin (MW 6500), insulin b 
chain (MW 3400) and insulin a chain (MW 2350). Lane A, protein solution after Sphadex 
G-50 chromatography. Lane B, protein solution after cation-exchange CM-Sephadex 
chromatography. Lane C, protein solution after reverse phase HPLC step. 
Table 4-2. Laser desorption time-of-flight mass spectrometry 
of the three forms of selenoprotein W. 
Protein forms  Mass* 
C-1  C-2a  9635±7 
C-2b  9371±11 
C-2c  9330±5 
* Mean of four individual sample determinations ± standard error. 106 
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Figure 4-6. MALDI mass spectrum of selenoprotein W. The sample was prepared and 
analyzed as described in the method section. A. MALDI mass spectrum of selenoprotein 
W fraction C-1. Singly, double and triply charged ions corresponding to the intact 
selenoprotein W are indicated as m/z 9635, 4815 and 3210 respectively. B. MALDI 
mass spectrum of selenoprotein W fraction C-2b. Singly and doubly charged ions 
corresponding to the intact selenoprotein W are indicated as m/z 9368 and 4691 
respectively. Internal antiviral standard is indicated as m/z 7517. 107 
Figure 4-7 presents the MALDI mass spectrum of purified selenoprotein W (C-2a) 
before and after dithiothreitol reduction. The major single protein ion is detected at M/Z 
9631 before dithiothreitol reduction, and the major single protein ion was converted to 
the lower mass form of 9327 Dalton after incubation with dithiothreitol. 
Figure 4-8 presents the MALDI mass spectrum of purified selenoprotein W 
endoproteinase Glu-C digestion. This enzyme hydrolyzes peptide bonds at the carboxyl 
side of glutamyl and aspartyl residues with preference at glutamyl bonds. The 3218 Da 
peptide fragment containing twenty nine amino acids (from 1st to 28th) is the same as the 
theoretical fragment mass deduced from monkey cDNA sequence in its corresponding 
segment. However, the 1767 Da peptide fragment containing 14 amino acids (from 35th 
to 48th) is 305 Da higher than the theoretical fragment mass deduced from monkey 
cDNA sequence of its corresponding segment. 
DISCUSSION 
Using 75Se label, the presence of a low molecular weight protein was first found 
in lamb muscle and heart (Pederson et al, 1972).  This protein was of interest because it 
was not labeled in muscle of lambs suffering from white muscle disease. Recently this 
protein was isolated from rat skeletal muscle and named selenoprotein W (Vendeland et 
al, 1993). This purification also used 75Se incorporation to identify the selenoprotein. It 
was inconvenient to use 75Se incorporation to identify this protein for purification from 
primate tissues. The present work indicates that the availability of functional antibodies 108 
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Figure 4-7. MALDI mass spectrum of selenoprotein W fraction C-2a before (A) and after 
(B) incubation with dithiothreitol at 50°C for 60 min. The mass peak has shifted from m/z 
=9631 to 9327. 109 
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Figure 4-8. MALDI mass spectrum of selenoprotein W fraction C-1 after incubation with 
endoproteinase Glu-C at 37° C for 18 hr. 3218 Da (labeled a) peptide fragment containing 
twenty nine amino acids (from 1st to 28th) is the same as the theoretical fragment mass 
deduced from monkey cDNA sequence in its corresponding segment. 1767 Da (labeled 
b) peptide fragment containing 14 amino acids (from 35th to 48th) is 305 Da higher than 
the theoretical fragment mass deduced from monkey cDNA sequence of its corresponding 
segment. 110 
for determination of selenoprotein W makes it possible to detect selenoprotein W levels 
in the ng range in whole tissue extracts or in chromatographic fractions. The purification 
procedure in combination with slot blot reported here offer further applications for 
isolation of selenoproteins with an unknown function without using isotope 'Se 
incorporation. 
The original muscle extract was concentrated to a small volume using an Amicon 
cell equipped with YM 3 ultrafiltration membrane. Loss of selenoprotein W during this 
step was lower than that experienced with ammonium sulfate precipitation which had been 
used in previous purifications from rat muscle. Gel filtration on a Sephadex G-50 column 
excluded most of the large molecular weight proteins (figures 4-1, 4-2).  Further 
purification using cation exchange chromatography on CM-Sephadex removed a large 
part of small molecular weight proteins, mostly cytochrome C (figure 4-3). Extensive 
washing before application of a sodium chloride gradient at a slow flow rate caused the 
early elution of selenoprotein W in a narrow salt concentration range in comparison to 
that used for purification of selenoprotein W from rat muscle (Vendeland et al, 1993). 
The final step using reverse phase HPLC chromatography separated all other proteins 
completely (figure 4-4) and resulted in an electrophoretically pure selenoprotein W with 
an estimated molecular weight of 10 KDa (figure 4-5). The molecular masses of this 
protein as further determined by MALDI-MS are 9635, 9371 and 9330 (figure 4-6, table 
4-2). The lowest mass of 9330 Da is in agreement with a theoretical molecular weight 
of selenoprotein W deduced from monkey cDNA sequence. Like rat selenoprotein W 
(Beilstein et al, 1996), different forms of selenoprotein W occur through derivation of the 111 
lowest mass form with two moieties of approximate masses of 41 and 305. The identity 
of the 41 Da moiety is unknown. The 305 Da moiety has been demonstrated to be the 
tripeptide, glutathione, which binds to selenoprotein W through a disulfide bond, as 
shown by reductive cleavage with dithiothreitol.  Glutathione removal caused the 
molecular mass to decrease by 305 Da (figure 4-7).  Selenoprotein W with bound 
glutathione is the major form isolated from monkey muscle. Similar to this selenoprotein 
from rat muscle, selenoprotein W from monkey muscle contains glutathione and a small 
molecular weight moiety. The nature of this low molecular moiety on selenoprotein W 
has not been identified from either rat or monkey muscles. 
Glutathione, a ubiquitous nonprotein thiol, is synthesized by all animals. It reacts 
nonenzymatically with free radicals and is also the source of reducing equivalents for 
reduction of hydroperoxides by glutathione peroxidases (Stadtman, 1990; 1991). The 
central role of glutathione in oxidant defense has been strengthened by discoveries of its 
ability to regenerate vitamin E and ascorbic acid after oxidation by free radicals (Meister 
et al, 1992). Selenoprotein W from both rats and monkeys contains glutathione. There 
are four cysteine residues (number 9, 32, 36 and 86) and one selenocysteine residue 
(number 12) in rat selenoprotein W (Vendeland et al, 1995) which could bind glutathione 
through disulfide or selenosulfide bonds. The primate selenoprotein W contains only two 
cysteine residues (number 9 and 36) and one selenocysteine (number 12). Glutathione 
was assumed to be bound to one of the cysteine (position 9 or 36) or selenocysteine 
(position 12) residues which are conserved in the proteins from all animals so far 
examined. In the protein from both rat and monkey only a single glutathione moiety is 112 
bound, suggesting that the binding is specific and functional. Peptide mapping using 
endoproteinase Glu-C digestion (figure 4-7) indicated that the peptide fragment 
containing twenty nine amino acids (position 1 to 28) did not contain the bound 
tripeptide. The fourteen residue peptide fragment (positions 35 to 48) had a mass 305 Da 
higher than the theoretical fragment mass deduced from the cDNA sequence. Thus, 
glutathione is attached to the 36th amino acid, cysteine, via disulfide bond. 
The biological function of selenoprotein W is not known. Selenium deficiency 
results in white muscle disease in lambs and calves (Muth, 1963) and Keshan disease in 
humans (Chen et al, 1980).  Muscle weakness has been shown to be prevented by 
selenium supplementation in patients on long term parenteral nutrition (Van Rij et al, 
1981; Brown et al, 1986). There is sufficient evidence that selenium is involved in normal 
muscle metabolism. All the known biological functions of selenium are mediated by its 
incorporation into selenoproteins (Stadman, 1991; 1996; Lee et  al,  1996).  The 
involvement of selenium in muscle function is therefore assumed to be mediated by 
selenoproteins.  There is evidence that weak oxidant defenses are important in the 
etiology of Keshan disease (Xia et al, 1994). Selenium has been known for several years 
to be an integral component of a few redox-type enzymes in prokaryotes (Zinoni et al, 
1987; Stadman, 1990, Bock et al, 1991) and in eukaryotes (Roctruck et al, 1973; Flohe 
et al, 1973).  It is reasonable to suspect that selenoprotein W may provide a similar 
function in tissues such as muscle and heart. The presence of bound glutathione in a 
large portion of the selenoprotein W isolated from rat and monkey muscle suggests that 
the tripeptide may be bound as a reactant in an enzymatic cycle. Selenoprotein W and 113 
its mRNA are higher in muscle and heart than in any other tissues examined in primates. 
The total chemical selenium concentration and activities of glutathione peroxidase are 
lowest in these tissues (see chapter 3). In selenium deficient sheep, selenoprotein W is 
undetectable in muscle and heart, but the levels in brain are the same as in control animals 
(Yu et al, 1997). This suggests that selenoprotein W levels in muscle and heart are more 
sensitive to selenium status than in the brain. Continuous investigations of the role of 
selenium in muscle metabolism may resolve the function of selenoprotein W. 
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ABSTRACT 
This study examined the effects of selenium on selenoprotein W mRNA in 
cultured L8 rat skeletal muscle cells. Selenoprotein W contains selenium as selenocysteine 
in primary peptide structure.  Levels of tissue selenoprotein W synthesis depend on 
selenium availability. Regulation of selenoprotein W synthesis by selenium levels could 
occur at either transcription or translation levels. Northern blot indicated that there was 
no significant changes (p<0.05) in selenoprotein W mRNAs during cell proliferation and 
differentiation.  Reduction of selenium concentration in the medium decreased the 
selenoprotein W mRNA levels.  Nuclear run-on experiments with isolated L8 nuclei 
showed the same rate of nascent selenoprotein W mRNA synthesis in cells cultured in 
either low selenium or selenium supplemented medium. This result indicates that the 
transcription rate of selenoprotein W gene is independent of selenium. Measurement of 
selenoprotein W mRNA half-lives in myoblasts treated with the transcription inhibitor, a­
amanitin, showed that selenoprotein W mRNA levels decreased over time with an 
estimated half-life of 57 hours for cells grown in low selenium medium.  Selenium 
treatment increased the selenoprotein W mRNA half-life two fold. These data suggest 
that selenium stabilizes selenoprotein W mRNA. 119 
INTRODUCTION 
Selenoprotein W was first reported as a missing component in muscle of lambs 
suffered from white muscle disease (Pedersen et al, 1972). Purification from rat muscle 
yields a mixture of four molecular weight forms, two of which bind reduced glutathione 
(GSH) (Vendeland et al, 1993; Beilstein et al, 1996). The cDNA was cloned first from 
rat skeletal muscle (Vendeland et al, 1995) and subsequently from the human, monkey, 
sheep and mouse (Gu et al, 1997). Western blot studies indicated that selenoprotein W 
is widely present in tissues of rats, sheep and monkeys, but is at its highest level in rat 
skeletal muscles (Yeh et al, 1995) and in both skeletal and cardiac muscles of sheep (Yeh 
et al, 1997a) and monkeys (see chapter 3). Tissue selenoprotein W and corresponding 
mRNA levels can be regulated by selenium in the rat (Vendeland et al, 1995; Yeh et al, 
1995).  Previous studies also have shown that selenium influences the levels of 
selenoprotein W in L8 rat skeletal muscle cells (Yeh et al, 1997b). Regulation of 
selenoprotein W gene expression in muscle cells is of interest because there is evidence 
that selenium is related to normal muscle function. White muscle disease (Schubert et al, 
1961), characterized by degeneration of both skeletal and cardiac muscle in lambs and 
calves, and Keshan disease (Chen et al, 1980), an endemic juvenile cardiomyopathy in 
a human population in China, are caused by selenium deficiency. Although the function 
of selenoprotein W is not clear, the evidence suggest a role associated with normal muscle 
metabolism. 
Selenoproteins are a small group of prokaryotic and eukaryotic polypeptides 120 
containing a unique amino acid, selenocysteine, in their primary structures. Selenocysteine 
is incorporated into selenoproteins at the translational step by specific UGA decoding 
translational machinery.  Using genetic and biochemical approaches in bacteria, the 
process of selenoprotein biosynthesis in prokaryotes has been well characterized (Bock 
et al, 1991). Although less is known about this process in eukaryotic systems, several 
components have been identified as essential for selenoprotein synthesis in higher animals 
(Berry et al, 1993; Hatfield et al, 1994; Hubert et al, 1996). The common feature of 
selenoprotein synthesis is that it is totally dependent upon the availability of selenium in 
the diet or growth medium. Regulations of glutathione peroxidase and selenoprotein P 
gene expression have been studies in selenium deficient or supplemented animals (Knight 
et al, 1988; Read et a1,1990; Burk et al, 1991) as well as in human populations (Hill et al, 
1996). The selenoprotein levels appear to be more sensitive to selenium status than their 
corresponding mRNAs levels, even though mRNAs levels directly affect the amount of 
template available for selenoprotein synthesis. 
The steady-state level of cytoplasmic mRNA depends upon its rate of formation 
as well as its degradation. Transcriptional control of mRNA formation has received the 
most attention, but post-transcriptional events such as processing of nuclear RNA, export 
from the nucleus and mRNA degradation are increasingly recognized  as processes 
affecting cytoplasmic mRNA levels  The 3'-UTR stem-loop mediated iron dependent . 
regulation of transferrin receptor transcripts is an excellent example (Casey et al, 1988). 
Interestingly, mammalian nucleotides for selenoproteins also have a stem-loop structure 
in the 3'-UTR. This stem-loop structure (SECIS element) is considered to be an essential 121 
structure for selenocysteine incorporation at the UGA codon (Berry et al, 1994; 
Stadtman, 1996). Since the effects of selenium on glutathione peroxidase, deiodinase and 
selenoprotein P gene transcription reside at the post-transcription step, the same step 
could be for the regulation of selenoprotein W gene expression. Thus in light of those 
studies, the present investigation was undertaken to determine whether selenium affects 
mRNA levels for selenoprotein W at the pre-transcriptional or post-translational levels. 
MATERIALS AND METHODS 
Materials 
L8 rat myoblast cells were obtained from American Type Culture Collection 
(Rockville, MD). Calf serum (CS) was purchased from Hyclone (Logan, UT). 
Dulbecco's modified Eagle's media (DMEM), penicillin/streptomycin solution, trypsin 
and DNA mass ladder were purchased from GIBCO (Grand Island, NY). Cell culture 
petri dishes were purchased from Corning (Corning, NY). GeneScreen Plus nylon 
membrane and a32P-UTP (800Ci/mmole) were purchased from DuPont/NEN (Boston, 
MA). Plasma Purification Kit was purchased from QIAGEN, Inc (Chatsworth, CA). PCR 
amplification Kit and RNasin were purchased from Promega (Madison, WI). Chroma 
Spin' Columns was purchased from Clontech (Palo Alto, CA). All the restriction 
enzymes were obtained from New England Biolabs Inc (Beverly, MA).  DIG 
Oligonucleotide Tailing Kit,  digoxigenin-dUTP, anti-DIG-AP conjugate, blocking 
reagent, luminescent detection substrate CSPD and E. coli tRNA were purchased from 122 
Boehringer Mannheim Biochemical ( Indianapolis, IN). DNase and RNase were 
purchased from Worthington Biochemical Co (Freehold, NJ). Non-radiolabeled 
nucleotides ATP, CTP and GTP and were obtained from Pharmacia (Piscataway, NJ). 
Hyperfilm was purchased from Amersham (Arlington Heights, IL). All other chemicals 
were of molecular biology grade and purchased from Sigma Chemical Co (St. Louis, 
MO). 
Cell culture and treatment 
Cells were grown in basal medium (DMEM, 100 units penicillin/ml, 100 lig 
streptomycin/ml and 44 mM sodium bicarbonate, pH 7.4) supplemented with 10% CS in 
a humidified atmosphere of 5% CO2 and 95% air at 37° C. The medium was changed 
every two days. To induce differentiation, cells were grown to confluence and medium 
was replaced with differentiation medium (basal medium plus 2% CS). Alterative ly, serum 
free medium (basal medium supplemented with 10-7M insulin, 10-7M dexamethasone, 5 
jig/m1transferrin, 1 i.tg/mllinoleic acid, 300 mg/mlfetuin, with or without selenium) was 
used (Allen et al, 1985). 
Experiment 1. 
The influences of proliferation and differentiation on selenoprotein W mRNA 
levels was examined. Myoblasts were cultured in basal media supplied with 10% CS. 
When the cells reached confluence, cells were either harvested as proliferating cells or 
maintained in 2% CS DMEM to induce differentiation. Differentiating cells were sampled 
for 8 days to examine the long term effect of differentiation. Alteratively, after inducing 123 
differentiation, the medium was replaced with serum-free medium or serum-free medium 
with 10-8M selenium to examine the effect of selenium status on selenoprotein W mRNA 
levels. 
Experiment 2. 
Effect of selenium concentration on selenoprotein W mRNA levels was examined. 
After two-days of induced differentiation, myotubes were incubated in serum-free medium 
supplemented with 0, 10', 104 and 10' M selenium as selenite for another 3 days. Cells 
were harvested and total cytoplasm RNAs were isolated from cells of each treatment. 
Nuclei were isolated only from the 0 and 10' M selenium treated groups. 
Experiment 3. 
The effect of selenium on selenoprotein W mRNA stability was examined. 
Myoblast cells were grown in 10% CS DMEM medium for 2 days and then changed to 
either serum-free media or serum-free media with 104 M selenium  as selenite. 
Transcription inhibitor, a-amanitin, was  added to the medium to block mRNA 
transcription. Cells were harvested at 0, 3, 6, 12, 24, 48 and 72 hours of incubation, and 
total cytoplasm RNAs were isolated for Northern blots. 
RNA extraction and Northern blot 
Total cellular RNA was isolated by the single step guanidine isothiocyanate 
procedure (Chomczynski and Sacchi, 1987). The final RNA pellet was dissolved in diethyl 
pyrocarbonate  treated  water  and  RNA  concentration  was  determined 
spectrophotometrically at 260 nm. The ratio of 260 nm/280 nm was used to check the 124 
quality of RNA purification. A sample of 20 lig of formaldehyde denatured RNA were 
size fractioned by electrophoresis on a 1.5% agarose-2.2 M formaldehyde gel, and the 
RNA blotted onto GeneScreen nylon membrane in 10x SSC (1.5 M NaCI and 0.15 M 
sodium citrate, pH 7.0) as transfer medium. The membrane was prehybridized at 65° C 
for 4 hours in medium containing 16.3% SDS, 0.25 M NaPO4, pH 7.2, 1 mM EDTA and 
0.5% blocking reagent. Hybridization of the cDNA probe was performed at 65° C 
overnight in the prehybridization with addition of 3Ong/m1 of dig-dUTP labeled probe. 
After extensively washing to remove excess probe and non-specific binding, hybridized 
RNA signals were detected by chemiluminesce detection system based on the procedure 
described by Krueger (1995). 
For reprobe, the membrane was boiled 7 min in 0.1% SDS  ,  then incubated at 
room temperature for 15 min in 0.1% SDS, 0.05 N NaOH solution and finally equilibrated 
in 2x SSC. The same conditions except the temperature was decreased to 45°C for the 
oligonucleotide probe were used for hybridization and post hybridization washing. The 
relative intensities of the resulting products were determined by scanning densitometry 
and analyzed by the Image-QuaNT program (Molecular Dynamics, Sunnyvale, CA). The 
level of selenoprotein W mRNA was expressed as the ratio of selenoprotein W 
mRNA/18s rRNA. 
Digoxigenin nuclei acid labeling 
Probes were prepared by PCR from cloned rat selenoprotein W cDNA and a-actin 
cDNA. Primers were designed based on the rat selenoprotein W cDNA start and 125 
termination signal regions or rat a-actin cDNA coding regions. Digoxigenin-labeled 
dUTP was incorporated into probe DNA during PCR amplification under standard 
conditions. The PCR products were then purified using Chroma Spin.' Columns and the 
concentration of probe was estimated  in comparison with DNA mass ladder 
electrophoresis. 
A universal 15-mer oligonucleotide probe for a small subunit of the 18s ribosomal 
RNA was used as an internal standard. This short oligonucleotide (1406R) (Lane at al, 
1985) with a sequence of ACGGGCGGTGTGTRC was the kind gift of Dr. Stephen 
Giovannon, Department of Microbiology, Oregon State University. Oligonucleotide was 
enzymatically labeled with terminal transferase by incorporation of a single digoxigenin­
labeled dUTP using standard conditions. The labeling and probe concentration were 
estimated by anti-digoxigenin immunological detection in comparison with a standard. 
Preparation of plasmid filters for nuclear run-on assays 
Cloned selenoprotein W cDNA in pExcell plasmid was used as a basic structure 
for constructing others. First, pExcell plasmid containing selenoprotein W cDNA was 
digested with restriction endonuclease EcoRl and then size separated by 1% agarose gel. 
The up-vector fragment was purified using Geneclean kit (BIO 101 Inc., La Jolla, CA) 
and then re-ligated with T4 ligase. The circle pExcell plasmid without insert was 
recovered by transformation into NM 522 competent cell. 
Forward and reverse primers with additional restriction enzyme Xho 1 in 5' end 
and HindIII in 3' end were designed based on the rat a-actin cDNA coding region. A 126 
single product consisting of 1.1 Kb rat a-actin coding region was obtained with PCR 
amplification using rat skeletal muscle cDNA library as the DNA template. The pExcell 
vector and PCR product were digested with Xho 1 and HindIII. Vector and insert 
fragments were purified from gel using Geneclean kit and ligated with T4 ligase. The 
recombinant pExcell plasmid containing a-actin cDNA was recovered by transformation 
into NM 522 competent cell. 
Plasmids were purified using QIAEX plasmid purification kit and linearized by 
restriction enzyme EcoRl for pExcell, Nco 1 for selenoprotein W cDNA pExcell and 
HindIII for a-actin cDNA pExcell. The linear plasmid DNA was denatured by NaOH and 
neutralized by 6x SSC. A 125 i.11 aliquot of sample (5 ug plasmid) was applied on 
Gene Screen nylon membrane slot under a low vacuum provided by a water aspirator. 
After air drying, filter was UV-cross linked and stored at 4°C. 
Nuclear run-on assays 
Five cultured dishes at densities of lx 106 cells/dish were used for each nuclear 
run-on assay. Cells were harvested and resuspended in 4 ml sucrose buffer I (0.32 M 
sucrose, 3 mM CaCL2, 2 mM MgOAc, 0.1 mM EDTA, 10 mM Tris-HCI pH 8.0, 1 mM 
DTT, 0.5% (v/v) Nonidet P-40) and broken in an ice-cold Dounce homogenizer with five 
to ten strokes of a pestle. The cell lysates were mixed with 4 ml sucrose buffer II (1.8 M 
sucrose, 5 mM MgOAc, 0.1 mM EDTA, 10 mM Tris-C1 pH 8.0,  1 mM DTT) and 
carefully loaded onto 4 ml of 1.8 M sucrose cushion with sucrose buffer Ito top off the 
gradient. The gradient was centrifuged at 30,000xg for 1  hour. Supernatants were 127 
removed by vacuum aspiration, and the nuclei were resuspended in ice cold glycerol 
storage buffer and frozen immediately. A 10 0 portion of each sample was removed, 
adjusted to 50 0 with 1xTES, boiled for 5 min, sonicated and the absorbance was 
measured at 260 nm to estimate the amount of nuclei in each sample. Each nuclei sample 
was adjusted to a concentration of 2.5 mg nuclei acid/ml (equal to 2.5 x 10' nuclei/n-11) with 
glycerol storage buffer and stored in liquid nitrogen. 
Transcription of nuclei and subsequent RNA isolation were performed based on 
procedures described by Greenberg and Bender (1983); 5x10' nuclei per sample were 
incubated for 30 min at 30°C in a 400 0 reaction buffer containing 20% glycerol, 30 mM 
Tris -HCI, pH 8.0, 2.5 mM dithiothreitol, 5 mM MgCl2, 0.05 mM EDTA, 0.5 units/ill 
RNasin, 0.5 mM each of ATP, GTP, CTP, and 125 pCi- 32P UTP (800Ci/mmole). The 
reactions were terminated by the addition of DNase I digestion, proteinase K digestion 
and subsequent phenol/chloroform/ isoamyl alcohol (25:24:1) extraction. Nuclear RNA 
was finally precipitated in ethanol. Equal counts per minute of the 32P- labeled transcription 
products were diluted in 50% formamide, 50 mM Na2PO4, 3 x SSC, 10 x Denhard solution, 
2501.1g/m1 salmon sperm DNA at 2x107 cpm/ml. Hybridization of de novo nuclear RNA 
transcript to cDNA immobilized on nylon membrane strip was performed at 42° C with 
shaking for 72 hours.  After hybridization, non specific binding was removed from 
membranes by washing with increasing stringencies. The membranes were exposed to X-
ray film for 7 days at -70°C with an intensifying screen. Autoradiograms were quantified 
by densitometric scanning and the level of selenoprotein W transcript in each slot was 
expressed as a ratio of selenoprotein W/a-actin RNA. 128 
mRNA half-life 
The rate of mRNA degradation in L8 cells grown in either low selenium medium 
or selenium supplemented medium was determined by measuring the changes of mRNA 
levels in the presence of the transcription inhibitor, a-amanitin. L8 myoblast cells were 
routinely grown in DMEM medium with 10% CS. After the cells reached 50-60% 
confluence, the medium was replaced with serum-free medium, and a-amanitin 2.5 µg/ml 
was added at the same time selenium was either removed or added. The cells were 
harvested 0, 3, 6, 12, 24, 48 and 72 hours. Total cellular RNAs were isolated by the 
guanidinium isothiocyanated procedure. Northern blots were performed with non­
radiolabeled probes to measure the relative levels of specific selenoprotein W mRNA. 
The amount of selenoprotein W mRNA at any time was expressed relative to control 
level. 
Statistical analysis 
ANOVA (analysis of variance) with Fisher's LSD (least-significant difference) was 
performed to determine statistical significance (Steel and Torrie, 1980). Significance was 
accepted at p<0.05. Each selenoprotein W/18s-rRNA ratio or selenoprotein W/a-actin 
ratio was expressed as means ± SE of the three replicates taken at each point. For 
selenoprotein W decay curves, selenoprotein W/18s-rRNA ratios were subjected to linear 
regression analysis followed by ANOVA. Regression equations were considered to be 
significantly different than zero or from one another if the probability was less than 5%. 129 
RESULTS 
Selenoprotein W mRNA levels during myoblast proliferation and differentiation 
Northern blots revealed the presence of selenoprotein W mRNA in both 
proliferating and differentiating cells (figure 5-1A). Quantitative analysis of Northern blot 
hybridization showed no significant difference in selenoprotein W gene expression 
between undifferentiated and differentiated cells (figure 5-1B). To examine the long term 
effect of cell differentiation on selenoprotein W gene expression, Northern blot analysis 
of total cellular RNA from L8 cells at various differentiation stages indicated that 
selenoprotein W was expressed continuously with time (figure 5-2A) and the levels of 
mRNA remained constant during different stages of differentiation (figure 5-2B). 
Effects of selenium status on selenoprotein W mRNA levels 
Calf serum usually contains selenium (3 x10-8 M), which may be adequate for 
selenoprotein gene expression. To examine the influence of selenium on selenoprotein 
W expression, L8 cells were cultured in serum-free medium with or without selenium 
after 2 days of differentiation and total RNA was isolated for Northern blots. Selenium 
depletion caused a drop in selenoprotein W mRNA levels (figure 5-3A) while selenium 
supplementation maintained the selenoprotein W mRNA at its original level (figure 5-3B) 
during the various differentiation stages. Quantitation of specific selenoprotein W mRNA 
signals at various times of cell differentiation indicated that the selenoprotein W mRNA 
levels decreased with time of selenium depletion(P<0.05) (figure 5 -3 C). However, when 
cells were cultured in serum-free medium with 104 M selenium, selenoprotein W gene 130 
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Figure 5-1. Selenoprotein W gene expression in proliferated and differentiated L8 cells. 
L8 rat skeletal muscle cells were cultured in DMEM medium with 10% CS at 
proliferation stages and DMEM medium with 2% CS at differentiation stages. A: Total 
RNA was isolated from 1 and 2 days of undifferentiated and differentiated cells and 
analyzed by Northern hybridization first with selenoprotein W cDNA probe and then 18s­
rRNA oligomer probe. Lanes 1-3: proliferation I day, lanes 4-6: proliferation 2 days, 
lanes 7-9: differentiation 1 day and lanes 9-12: differentiation 2 days. B: Bar graph 
analysis depicts the selenoprotein W mRNA levels standardized to levels of 18s-rRNA to 
correct for loading variations. Error bars indicates standard error of the mean (n=3). 131 
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Figure 5-2. Effects of long term differentiation on selenoprotein W mRNA levels. L8 
cells were grown in DMEM with 10% CS until they reached confluence. The medium 
was replaced with DMEM plus 2% CS to induce differentiation.  A: Total RNA was 
extracted following 1-8 days of differentiation and analyzed by Northern hybridization 
first with selenoprotein W cDNA probe and then 18s-rRNA probe. Lanes 1-3: initial 
control, lanes 4-6: 3 days of differentiation, lanes 7-9: 4 days of differentiation, lanes 10­
12: 5 days of differentiation, lanes 13-15: 6 days of differentiation, lanes 16-18: 7 days of 
differentiation, lanes 19-21: 8 days of differentiation. B: Bar graph analysis depicts the 
selenoprotein W mRNA levels normalized to levels of 18s-rRNA to correct for loading 
variations. Error bars indicate standard error of the mean (n=3). 132 
was expressed continuously. There were no significant (P>0.05) differences with time of 
incubation (figure 5-3C). 
To further establish the relationship between selenoprotein W mRNA in cytoplasm 
and selenium concentration in medium, concentrations of supplemented selenium were 
varied in serum-free medium. As shown in figure 5-4A,  additional selenium in the 
incubation medium caused an increase of selenoprotein W mRNA levels. Quantitative 
densitometries analysis of Northern signals indicated that selenoprotein W mRNA levels 
were higher in cells cultured with added selenium than in those cultured in low selenium 
medium (p<0.05). Selenium concentration as low as 10-8 M increased selenoprotein W 
mRNA above basal levels. There were no differences among selenium treated groups 
(p>0.05) (figure 5-4B). 
Transcriptional run-on analysis 
Nuclear run-on assays were performed to examine the transcription rates of 
selenoprotein W mRNA in L8 cells grown in serum-free medium with or without addition 
of 10-7 M selenium. Figure 5-5A shows a typical autoradiogram from a transcriptional 
run-on analysis in which nascent RNA transcripts corresponding to the selenoprotein W 
mRNA were detected by rat selenoprotein W cDNA probe. Hybridization of the RNA 
transcripts was specific as no activity was detected with non specific pExcell plasmid 
DNA. The transcripts were normalized to a-actin RNA to account for slight variations 
in total RNA transcript concentration in the hybridization solution.  Part of the cells were 
reserved for cytoplasm RNA isolation and Northern hybridization. Figure 5-5B shown 133 
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Figure 5-3.  Effects of selenium on selenoprotein W mRNA levels at various 
differentiation stages. L8 cells were grown in serum-free medium with or without 104 
M selenium after 2 days of differentiation. A: Total RNA was extracted following 1-8 
days of differentiation in the absence of selenium. B: Total RNA was extracted following 
1-8 days of differentiation in the presence of selenium. Northern blots were performed 
first with selenoprotein W cDNA probe and then 18s-rRNA probe. Lanes 1-3: initial 
control, lanes 4-6: 3 days, lanes 7-9: 4 days, lanes 10-12: 5 days, lanes 13-15: 6 days, 
lanes 16-18: 7 days, lanes 19-21: 8 days of differentiation. C: Bar graph analysis depicts 
the selenoprotein W mRNA levels normalized to levels of 18s-rRNA to correct for 
loading variations. Error bars indicate standard error of the mean (n=3). Treatments 
which do not share a common superscript differ significantly (P<0.05). 134 
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Figure 5-4. Effects of different levels of selenium in cell medium on selenoprotein W 
mRNA levels.  Myotubes at 2 days of differentiation were incubated in serum-free 
medium with various concentrations of selenium for 3 days. A: Northern blot analysis 
first with selenoprotein W cDNA and 18s-rRNA probes. Lanes 1-4: serum-free medium 
without selenium, lanes 5-8: serum-free medium with 10-8 M selenium, lanes 9-12: serum-
free medium with 10'M selenium, lanes 13-16: serum-free medium with 10' M selenium. 
B: Bar graph analysis depicts the selenoprotein W mRNA levels normalized to levels of 
18s-rRNA to correct for loading variations. Error bars indicate standard error of the mean 
(n=4). Treatments which do not share a common superscript differ significantly (P<0.05). 135 
one set of Northern blots developed with selenoprotein W cDNA and a-actin cDNA 
probes. The levels of selenoprotein W mRNA were normalized to that of a-actin mRNA 
to account for slight variations in sample loading. As shown in figure 5-5C, nuclear run-
on analysis revealed no difference in transcription rate of selenoprotein W mRNA in cells 
grown in either selenium depleted or supplemented medium (p>0.05), however, the level 
of selenoprotein W mRNA was higher in cells incubated in medium containing selenium 
than those in selenium depleted medium (P<0.05). Thus, selenium depletion caused a 
decrease of selenoprotein W mRNA resident at a post-transcriptional stage. 
Selenoprotein W mRNA half-life measurement 
L8 myoblast cells were cultured in DMEM medium with 10% CS for 2 days and 
then medium was replaced with serum-free medium with or without added selenium. 
Further RNA synthesis was blocked with 2.5 µg/ml of a-amanitin and the decay rate of 
pre-exiting selenoprotein W mRNA was monitored by Northern blots. When cells were 
grown in low selenium medium, selenoprotein W mRNA levels decreased progressively 
over time (figure 5-6A), while selenoprotein W mRNA levels in cells grown in selenium 
supplemented medium decreased significantly slower for the duration of the experiment 
(figure 5-6B). Quantitation of Northern blots scanning densitometries and linear curve 
analysis indicate significant difference between the low and high selenium groups. The 
estimated half-lives of selenoprotein W mRNA were 56 hours in the absence of selenium 
but 120 hours in the presence of selenium (figure 5-6B). 136 
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Figure 5-5. A: Representative autoradiography from one set of experiments showing 
the amount of RNA transcripted in vitro by nuclei from cells grown in serum-free medium 
with 10' M selenium or without added selenium for 3 days following 2 days 
differentiation. The labels on the left indicate the cDNA probes used to identify the newly 
synthesized mRNA. Selenoprotein W probe including full length rat selenoprotein W 
cDNA to detect specific selenoprotein W gene transcripts, a-actin probe including rat 
a-actin cDNA codon region as a positive control and pExcell plasmid without any insert 
as a negative control. B: One set of Northern blot of cellular RNA hybridization with 
selenoprotein W cDNA and a-actin cDNA probes. C: Bar graph comparison of the 
steady-state selenoprotein W mRNA levels with newly synthesized selenoprotein W 
mRNA. Selenoprotein W mRNA levels were normalized to a-actin mRNA levels. Error 
bars indicate standard error of the mean (n=3). Treatments which do not share a common 
superscript differ significantly (p<0.05). 137 
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Figure 5-6. Effects of selenium on selenoprotein W mRNA stability. L8 myoblasts were 
cultured in DMEM medium with 10% CS for 2 days and replaced with serum- free 
medium with either 10' M selenium or no selenium. At the same time, 2.5 1.1g/m1  a­
amanitin was added to block transcription. A: Northern blot of total RNA isolated from 
cells grown in selenium depleted medium. B: Northern blot of total RNA isolated from 
cells grown in selenium supplemented medium. Lanes 1-3: initial, lanes 4-6: 3 hours, 
lanes 7-9: 6 hours, lanes 10-12: 12 hours, lanes 13-15: 24 hours, lanes 16-18: 48 hours, 
lanes, 19-21: 72 hours. C: Linear curve analysis depicts the selenoprotein W mRNA 
decay over 72 hours following a-amanitin addition to block transcription. Selenoprotein 
W levels were normalized to levels of 18s-rRNA to correct for loading variations and 
expressed as a percent of time zero. Error bars indicate standard error of the mean (n=3). 138 
DISCUSSION 
In the present study, the expression and regulation of selenoprotein W gene were 
investigated in vitro with L8 cell line. Selenoprotein W is expressed both in proliferating 
myoblasts and in differentiating myotubes. There was no difference in selenoprotein W 
mRNA levels between growing cells and cells induced to differentiation (figure 5-1). 
Selenoprotein W mRNA levels remained constant at the various stages of differentiation 
when cells were cultured in standard differentiation medium (DMEM+2%CS) (figure 5­
2).  This result contradicts a previous study in our research laboratory that showed a 
decrease in selenoprotein W during differentiation (Yeh et al, 1997b). A possible 
explanation is that the selenoprotein W protein levels are more sensitive to selenium status 
change than are selenoprotein W mRNA levels. The proliferation medium contains 10% 
CS whereas the differentiating medium contains 2% CS. The decrease in selenoprotein 
W during differentiation was due to the lower selenium concentration which was provided 
by CS in the medium. When differentiation was induced by changing medium from 10% 
CS to 2% CS, selenoprotein W synthesis was less efficient as selenium availability in the 
medium was decreased. However, this difference of selenium concentration in medium 
is not enough to alter the selenoprotein W mRNA levels. To determine further whether 
selenoprotein W mRNA maintenance during cell differentiation is selenium dependent or 
not, serum-free medium was used to culture myotubes in the absence of selenium or in 
the presence of selenium at a level equal to that in 2% CS. The results indicated that 
selenoprotein W mRNA levels decreased simultaneously with time of differentiation as 139 
selenium is reduced in medium, while selenoprotein W mRNA levels remained constant 
during differentiation if selenium was present in the medium (figure 5-3).  Thus, the 
maintenance of selenoprotein W mRNA levels is dependent on selenium availability 
instead of cell stage. 
Effects of medium selenium concentration indicated that a selenium concentration 
at 10-8M is adequate to maintain the selenoprotein W expression (figure 5-4). Although 
the increase in selenoprotein W mRNA was slightly higher at 10' M compared to 104 
M selenium, the difference was not statistically significant. The increase of selenoprotein 
W mRNA with selenium exposure is consistent with a previous in vivo study which 
demonstrated that selenoprotein W mRNA level increased from deficient to 0.1 ppm 
dietary selenium in the rat, but there was no further increase with dietary selenium 
between 0.1 and 4 ppm (Vendeland et al, 1995; Yeh et al, 1996). The selenoprotein W 
mRNA level does not parallel to the selenoprotein W content as shown in the L8 cells 
(Yeh et al, 1997b). In the in vivo system, selenoprotein W synthesis also showed a dose-
response pattern.  Selenoprotein W mRNA level was reduced to 25% of control but 
selenoprotein W level was 12.5% of control when dietary selenium in the diet decreased 
from 0.1 ppm (control) to no added selenium. Selenoprotein W mRNA remained constant 
whereas selenoprotein W content increased when dietary selenium was increased from 0.1 
ppm to 4 ppm (Vendeland et al, 1995). In view of other selenoproteins, the regulation 
system is very similar.  Levels of mRNAs of cellular glutathione peroxidase and 
selenoprotein P fell to 3% and 11% of control respectively whereas cellular glutathione 
peroxidase activity was only 0.8% of control (Chada et al, 1989), and selenoprotein P 140 
concentration was 4.3% of control (Hill et al, 1992). Thus, selenium effects selenoprotein 
synthesis but not always the selenoprotein mRNAs levels.  Selenium regulates 
selenoprotein gene expression not only at mRNA level but also at the protein level. Even 
though mRNA levels directly influence protein synthesis, cotranslational incorporation of 
selenocysteine into selenoprotein at the UGA codon of selenoprotein mRNA is dependent 
on both selenium availability and the efficiency of decoding machinery. 
Studies have demonstrated that various selenium levels effect on selenoprotein 
synthesis at multiple levels (Burk and Hill, 1993). Selenium is used in de novo synthesis 
of selenoprotein from pre-existing mRNA by cotranslational insertion of selenocysteine 
into its primary peptide sequence and selenium also effects on steady-state levels of 
selenoprotein mRNA. In the in vitro transcriptional run-on analysis, RNA synthesis 
consists of elongation and completion of synthesis of previously initiated RNA molecules. 
Incorporation of 32P -UTP into initiated RNA indicated that these isolated nuclei were 
capable of transcript elongation. Results of the transcription assay using nuclei isolated 
from L8 cells showed that nuclei from selenium deficient cells have the ability to 
synthesize the same amount of selenoprotein W pre -mRNA as nuclei from selenium 
treated cells even though the steady-state level of selenoprotein W mRNA is lower in cells 
cultured in low selenium medium compared to selenium supplemented medium (figure 5­
5). These results are consistent with the results obtained on gene regulation of other 
selenoproteins. Studies on glutathione peroxidase, 5'-deiodinase and selenoprotein P in 
rat showed a common feature of decreasing mRNA levels for all of these genes as a 
consequence of a limited selenium and mRNA levels were quickly elevated when selenium 141 
was increased in the diet (Toyoda et al, 1989). Nuclear run-on analysis demonstrated that 
the decrease in mRNA levels of glutathione peroxidase, 5'-deiodinase and selenoprotein 
P due to selenium deficiency was because of post-transcriptional regulation (Bermano 
et al, 1995; Burk and Hill, 1994). Similar to glutathione peroxidase, 5'-deiodinase and 
selenoprotein P, regulation of selenoprotein W mRNA by selenium in the L8 cell line 
resides at a post-transcriptional site.  Therefore, selenium status affects the stability of 
selenoprotein W mRNA. 
The steady-state levels of any transcript represent a balance between its rate of 
nuclear synthesis, and its rate of cytoplasmic degradation. Hence, the steady-state levels 
of functional mRNAs are determined,  in part, by their rates of degradation. When 
transcription was blocked by a-amanitin, the difference of decay curve of selenoprotein 
W mRNA represented the different rate of mRNA degradation. This study is the first to 
examine the influence of selenium on mRNA stability.  In the absence of selenium, 
selenoprotein W mRNA level decreased with an estimated half-life of 57 hours, whereas 
in the presence of selenium selenoprotein W mRNA was much more stable with a half-life 
of 120 hours (figure 5-6). 
The mechanism of selenium stabilization of selenoprotein W mRNA is not clear. 
At least two possible models could be investigated further on the mechanism by which 
selenium stabilizes selenoprotein W mRNA.  The first model is covalent nuclear 
modifications to the transcript which involves alterations to the 5' or 3' UTR influencing 
changes in mRNA stability.  This could be tested by blocking transcription with a­
amanitin prior to exposing the cells to selenium. This experiment would indicate whether 142 
or not selenoprotein W mRNA stabilization is dependent upon the production of new 
transcripts. The second model is that selenoprotein W mRNA stabilization might be 
mediated by protein-nucleic acid interaction in the cytoplasm. This could be tested by 
comparing the mRNA decay curves of cells maintained in the presence or absence of a 
translational inhibitor such as cycloheximide. This experiment would indicate whether or 
not selenoprotein W mRNA stabilization is dependent upon the de novo synthesis of other 
proteins. 
The stability of mRNA is probably regulated through the interaction of cis-
elements with RNA-binding proteins that can effect the susceptibility of RNA to 
nucleolytic attack. A well-characterized example is the iron-responsive element (IRE) 
present in the 3'-untranslated region of transferrin receptor mRNA (Casey et al, 1988). 
The IRE forms a stem-loop structure that is recognized by an IRE-binding protein. This 
association modulates the stability of transferrin receptor mRNA in response to iron 
availability or deprivation (Winner and Kuhn, 1988). Selenoprotein W mRNAs contain 
a stem-loop structure in the 3'-UTR analogous to the conserved SECIS element in other 
mammalian selenoprotein mRNAs (Gu et al, 1997). The SECIS element is considered to 
be an essential structure for selenocysteine incorporation at the UGA codon (Berry et al, 
1993; 1994; Walczak et al, 1996). It is possible that the same stem-loop structure has a 
dual function involved in selenocysteine insertion as well as selenoprotein mRNA 
stabilization. RNA binding proteins with the ability to bind the SECIS have been 
identified (Shen et al, 1995; Hubert al et, 1996). Alteratively, other critical cis-elements 
exist in some, as yet unidentified region of selenoprotein mRNA. Functional studies of 143 
these RNA binding proteins may finally elucidate the relationship between the SECIS 
element and UGA read through and selenoprotein mRNA stabilization. 
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CHAPTER 6 
CONCLUSION 
Evidence for  a low molecular weight protein containing selenium as 
selenocysteine, now called selenoprotein W,  was obtained a number of years ago. 
However, only recently, the use of molecular biological techniques made it possible to 
characterize this selenoprotein more fully. The cDNA of selenoprotein W cloned from 
rat skeletal muscle demonstrated that selenocysteine was coded by  an in-frame UGA 
codon. In the present studies, the cDNAs for skeletal muscle selenoprotein W were 
cloned from human, rhesus, sheep and mouse by employing rat selenoprotein W cDNA 
as a probe. Selenoprotein W gene is highly conserved.  The coding region of the 
nucleotide sequences and their predicted amino acid sequences are 80 and 83% identical, 
respectively, among these five species. This conserved feature of selenoprotein W could 
be important for its function even though it is not clear. UGA directed selenocysteine 
insertion in mRNA of primates, but specified both selenocysteine incorporation  and 
translation termination in a single mRNA of rodents and sheep. The SECIS  elements 
found in the 3' untranslational regions of selenoprotein W cDNAs in five species. 
Important features common to all known SECIS elements are conserved in all. These 
SECIS elements are essential to mediate the selection of the proper selenocysteine UGA 
codon in eukaryotes (Berry et al, 1993; 1994; Martin et al, 1996). 
Selenoprotein W gene is expressed widely in different animals and in various 148 
tissues. The mRNAs were detected in multiple tissues but highest in skeletal muscle and 
cardiac tissue of monkeys and humans. The antibodies raised against rat selenoprotein 
W peptide detected selenoprotein W in tissues of rats, mice, sheep, cattle and guinea pigs; 
but failed to recognize the selenoprotein W in primate tissues. There are three differences 
in the amino acid composition of this region between rodents and primates, but only one 
between sheep and primates. The 17th amino acid, proline in rodents and sheep, but 
serine in primates, is assumed to result in the difference of immunoreactivity. The absence 
of proline at this position in primates may account for the low affinity in antibodies raised 
against the human peptide. A different approach in which a single base (Secys codon 
TGA was replaced with Cys codon TGT) was changed to obtain mutant human 
selenoprotein W after cloning into a prokaryotic expression vector. This mutant 
selenoprotein W was used as the antigen for antibody generation. These antibodies 
raised against this mutant human selenoprotein W appear to be fully sufficient for 
detecting selenoprotein W in primate tissues. Western blots indicated that selenoprotein 
W is highest in skeletal muscle and cardiac muscle, lowest in liver.  Levels of 
selenoprotein W were higher in female than in male monkeys. This gender difference 
would appear to be a worth while study to pursue. Differences due to gender were found 
for GPX (Prohaska and Sunde, 1993). 
Selenoprotein W was purified from monkey skeletal muscle by chromatography. 
Matrix-assisted laser absorption/ionization time-of-flight mass spectrometry indicated that 
three forms of selenoprotein W were present. The lowest mass form, 9330 Da, is the 
form of selenoprotein W without any adducts. The highest mass form, 9635 Da, has been 149 
shown to be the lowest mass form with glutathione bound to it which is attached to the 
36th amino acid (cysteine) of selenoprotein W through the disulfide bond. The ten amino 
acids around this cysteine residue are conserved in all five animal species examined. The 
GSH bound to selenoprotein W may be important for the metabolic function of this 
selenoprotein similar to that shown for the activities of GPXs (Ganther and Kraus, 1984). 
This tripeptide could be reactants and/or products of an enzymatic cycles. Weak oxidant 
defenses have been demonstrated to be important in the etiology of selenium deficiency 
diseases.  Selenoprotein W is absent in muscle and heart of the white muscle disease 
lambs, whereas it is present at highest levels in muscle and heart of normal animals. These 
evidences suggest an oxidation/reduction function of this protein in the local tissues. The 
other mass form, 9371 Da, is assumed to be the lowest mass form bound to a small 
moiety, 41 Da, which is speculated to be calcium, although the preliminary calcium 
binding experiment did not support this conclusion. Examination of selenoprotein W 
amino acid sequences revealed a region, amino acids 60-71, which is highly homologous 
with the calcium binding domain of calmoludin (Takeda and Yamamoto, 1987). Calcium 
is important for normal muscle functions. Sarcoplasmic reticular tubules from selenium 
deficient sheep have reduced ability to sequester calcium (Tripp et al, 1993). Injection 
of selenium into white muscle disease lambs resulted in increased uptake of calcium by 
sarcoplasmic reticulum. Selenium involvement in normal muscle metabolism could be 
through selenoprotein W which is mediated by binding glutathione and/or calcium. 
The regulation of selenoprotein W gene expression was studies in vitro using rat 
skeletal muscle cells. Removal of selenium in medium decreased the selenoprotein W 150 
mRNA levels, but addition of selenium increased the selenoprotein W mRNA levels. 
Normal cell culture medium with 2 or 10% calf serum containing 10-8 M selenium is 
sufficient for selenoprotein W gene expression. There was no difference in selenoprotein 
W mRNA levels between proliferating or differentiating cells. Even though the mRNA 
levels of selenoprotein W were higher in cells grown in high selenium medium than in low 
selenium medium, selenoprotein W gene transcription rate was independent of selenium, 
but mRNA stabilization was influenced by selenium addition.  Similar to other 
selenoproteins such as GPXs, 5'DI and selenoprotein P (Bermano et al, 1995; Burk and 
Hill, 1994), the regulation of selenoprotein W resides at the post-transcription levels. 151 
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ABSTRACT 
The distribution of selenium between the plasma fractions was investigated in 
guinea pigs fed various levels of dietary selenomethionine (Semet) and in humans 
living in different areas of China with different selenium status. Two experiments 
were conducted with guinea pigs fed different levels of selenium as Semet. There was 
a corresponding increase of selenium concentration in liver, kidney, brain, testis, 
spleen, heart and muscle with each increase of dietary selenium, but there were no 
increases of glutathione peroxidase (GPX) activity in liver, brain, testis, heart or 
muscle in pigs fed any of the selenium levels as compared to controls. Increases of 
GPX activity occurred in kidney with  micrograms and above but with 0.5 1 
micrograms and above in spleen of pigs fed various levels of selenium.  On a 
percentage distribution basis, the selenium in selenoprotein P decreased and that in the 
albumin fraction increased with increased dietary intakes of selenium as Semet. The 
ratios of selenium to albumin in either the plasma or the albumin fractions increased 
with each increase in dietary selenium. When selenate was compared to Semet at 4 
micrograms per gram diet, the greatest amount of selenium was in the selenoprotein 
P fraction whereas the greatest amount was in the albumin fractions of pigs given 
Semet. Plasma from subjects living in different areas of China showed similar patterns 
to the guinea pigs. The greatest percentage of selenium was in the albumin fraction 
of subjects living in the high selenium areas whereas the greatest amount was in the 
selenoprotein P fractions in subjects living in deficient and adequate areas of China. 171 
Again, increases of the ratios of selenium to albumin in either the plasma or the 
albumin fraction occurred with increases of selenium intake.  The distribution of 
selenium in plasma fractions of an American subject taking high levels of selenium 
enriched yeast was similar to that of Chinese living in the high selenium area of that 
country.  The results indicate that the distribution of selenium in plasma fractions 
reflect the levels of dietary intakes of Semet. 
INTRODUCTION 
Although initially selenium was thought of as a carcinogenic element, it is now 
recognized by most researchers as an anticarcinogenic element (Combs and Combs, 
1986). There has been over 100 experiments with laboratory animals with various 
chemical carcinogens and with several forms of selenium and the majority of them 
showed positive results.  This animal data took on additional significance when 
information was obtained that selenium may indeed alter cancer in humans. There 
have been three human trials with selenium and cancer conducted and all of them have 
shown positive results. Addition of selenium to salt significantly reduced the incidence 
of liver cancer in a Chinese population (Li, Huang, and Liu, 1993). After 5 years of 
supplementation with selenium, vitamin E and carotene, the incidence of stomach and 
esophageal cancer in a Chinese population was significantly reduced (Blot et al, 1993). 
A 50% reduction in the incidence of colon and prostate cancer was found after 7 years 
of supplementation with selenium in an American population (Clark et al, 1996). 172 
With this increased interest in selenium and cancer, it is desirable to have a 
biological marker to indicate impending selenium toxicity problems before they occur. 
Excessive intakes of selenium in humans result in fingernail changes and loss of hair 
(Yang et al, 1989a), but biochemical markers are needed to indicate these problems 
before they occur. This is one of the major purpose of the present studies. There are 
three major selenium containing proteins in the plasma, which are glutathione 
peroxidase (GPX), selenoprotein P and albumin. With adequate selenium intakes the 
greatest amount of selenium is present in the selenoprotein P fraction of humans (Hill 
et al, 1996 and Deagen et al, 1993). However, the greatest percentage of selenium is 
present in the albumin fraction with excessive intakes of selenium as selenomethionine 
(Semet) in primates ( Whanger et al, 1994a).  It was reasoned that the ratio of selenium 
to albumin may be used to indicate impending selenium toxicity problems. Rats were 
initially investigated but were found to be unsuitable because very little changes occur 
with various intakes of Semet (Whanger et al, 1994b). Preliminary work with guinea 
pigs suggested that they may be appropriate animals to study this relationship. To 
obtain confirming data, plasma samples were obtained from Chinese subjects living in 
selenium deficient, adequate or excessive areas of China. The present report gives the 
results of these investigations and suggest that the ratios of selenium to albumin might 
be a suitable biological marker for impending selenium toxicity when Semet is the 
dietary form of selenium. 173 
EXPERIMENTAL PROCEDURES 
Animal experiments 
Two experiments with weanling guinea pigs were conducted.  In the first 
experiment the pigs were fed a basal commercial diet (Purina guinea pig chow, St. 
Louis, MO) or this diet with additions of either 0.5, 1.0, 2.0 or 4.0 micrograms of 
selenium as Semet per g diet. For comparative purposes, an additional group of pigs 
were fed 4 ag selenium as selenate per g diet. Guinea pigs were fed this diet or this 
plus either 4.0, 6.0, or 8.0 pg selenium per g diet in the second experiment. Semet 
(or selenate in experiment one) were dissolved in water and sprayed on the guinea pig 
chow pellets.  This was allowed to air dry and these pellets fed to the pigs on ad 
libitum basis for eight weeks.  The pigs were injected with pentobarbital (80 mg/kg) 
and blood taken by heart puncture. The pigs were decapitated under anethesisa with 
a guillotine. After the blood was centrifuged at 800 x g for 10 min., the plasma was 
frozen until it was fractionated. Liver, kidney, brain, testis, spleen and muscle (from 
the leg) were removed for selenium analysis and for GPX activity assay immediately 
frozen on dry ice and kept frozen at -80 C until analysis. The basal pig chow analyzed 
0.7 n selenium per g diet. This study was approved by the animal care committee at 
Oregon State University. 
Human experiments 
Blood was collected from women (ages 20-33) living in deficient (Dechang 
county of Liangshan Prefecture, Sichuan Province), adequate  (in rural area near 174 
Beijing) and excessive (Huabei village in Enshi county, Exi prefecture, Hubei 
Province) selenium areas of China.  The selenium intake by these subjects were 
estimated to be respectively about 30, 100 and 750 micrograms selenium per day (Xia 
et al,  1992a, b). They had lived their entire lives in these respective areas of China. 
The erythrocytes were removed by centrifugation and the plasma frozen with liquid 
nitrogen.  The plasma was kept frozen until analyses were done.  These plasma 
samples were sent while frozen on dry ice by a commercial airline from China to 
Oregon State University. Selenium concentration and GPX activities were determined 
on these samples.  For comparative purposes blood was taken from an American 
subject (a 45 year man) who had taken 800 to 1,000 itg selenium as selenium enriched 
yeast for 6 months and the plasma separated into GPX, selenoprotein P and albumin 
fractions.  This study was approved by Oregon State University committee for the 
Protection of Human Subjects and by a special Institutional Review Board convened 
at the Chinese Academy of Preventive Medicine in Beijing. 
Methods 
Both human and guinea pig plasma were chromatographed on dual columns to 
separate the GPX, selenoprotein P and albumin fractions (Deagen et al, 1993). The 
selenium content in each of these fractions were determined and the sum of them used 
to determine the recovery of selenium in comparison to the values obtained with whole 
plasma. The selenium content in each fraction was expressed as nanogram per ml 
plasma. 175 
After digestion with nitric and perchloric acids, the selenium content was 
determine by a semiautomatic flourometric procedure (Brown and Watkinson, 1977). 
GPX activity was assayed by the coupled enzyme procedure (Paglia and Valentine, 
1967). Albumin content in both whole plasma and in the albumin fraction from the 
dual column was determined by a colorimetric method (Sigma Chemical Company 
Diagnostic Kit, Number 625-2) and the ratios of selenium per mg albumin calculated 
for each of these fractions. The data was subjected to statistical analysis using the 
multiple t-test (Steel and Torrie, 1980). 
RESULTS 
There were no differences in feed intake of the guinea pigs in either 
experiment. The estimated daily intake was 30-40 gms per animal, and thus higher 
intakes of selenium with commercial guinea pigs diets are required to obtain selenium 
toxicity. 
Except for those given 0.5 mg selenium per kg diet, a significant increase in 
selenium content occurred in all plasma fractions in animals given selenium in 
comparison to plasma from the controls (figure A-1). The greatest amount of selenium 
was present in the selenoprotein P fraction in plasma from control guinea pigs, but the 
greatest amount of selenium was in the albumin fraction in pigs fed the diet with 2 mg 
selenium per kg diet.  There were no differences in the selenium content in the 
selenoprotein P fractions from pigs fed 1 or 2 mg selenium per kg diet, but the amount 176 
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Figure A-1. Selenium content in different fractions of plasma from guinea pigs fed 
diet with no addition (control) or additions of various levels of selenomethionine. The 
means ± standard errors of selenium concentrations in plasma were 116 ± 7, 187 ± 
10, 333 ± 30 and 470 ± 63 ng/ml respectively for animals fed control diet or this plus 
0.5, 1 or 2µg selenium as selenomethionine per g diet.  Bars indicate means ± 
standard errors of the means (n=3). Different superscripts indicate significant 
differences (p <0.05). 177 
of selenium in the albumin fraction was higher in pigs fed the diet with 2 mg selenium 
than those fed the diet with 1 mg selenium per kg diet.  Increases of the selenium 
concentration in guinea pig tissues (table A-1) did not correspond with the increase 
of GPX activity (table A-2) which indicates that the amount of selenium in the basal 
diet was sufficient to meet dietary needs. 
The selenium content in these fractions from pigs of the second experiment is 
shown in figure A-2.  Similar to the first experiment the selenium content in these 
fractions in plasma from pigs fed diets with 4 mg selenium per kg diet or greater was 
significantly higher than in the plasma from control animals. The greatest amount of 
selenium was in the albumin fraction of pigs fed the diets with 6 or 8 mg selenium per 
kg diet, which was significantly higher than in this fraction of pigs fed the diet with 
4 mg selenium per kg. 
Selenium was higher in all fractions in plasma from animals fed the diet with 
Semet than those fed the same amount of selenium as selenate in experiment 1 (figure 
A-3). The greatest difference between those fed selenium as selenate or as Semet was 
in the albumin fractions. 
The percentage distributions of selenium between the three fractions with the 
combined data from both experiments are shown in figure A-4. With increased intake 
of dietary selenium, the percentage of selenium in the selenoprotein P fraction 
decreased whereas that in the GPX and albumin fractions increased with increased 
selenium intakes. However, the greatest increase occurred in the albumin fractions. 178 
Table 1. Selenium Concentrations in different tissues of guinea pigs fed various 
levels of selenomethionine or one level of selenate 
group*  liver  kidney  brain  testis  spleen  heart  muscle
 
control  4.410.2a  3.0+0.5'  1.2+0.1'  1.6±0.3a  1.5+0.1'  1.6+0.1'  1.1+0.2'
 
Se-met
 
0.5ppm  13.7+4.5''  6.9±1.6ab  1.8+0.2'1'  2.6± 0.2a  2.5+0.2'  2.9±0.5ab  2.3+0.3'
 
1.0ppm  24.3±3.7bc  7.6±2.1b  3.0±0.5b  3.1+0.7'  4.1±0.2c  5.5+0.5'  3.8 +0.2b 
2.0ppm  38.2+0.3d  10.2±0.6b  4.8+0.6'  6.8±0.6b  6. 7+0. 1 d  8.7±0.8d  7.1 +0.5° 
4.0ppm  56.5±7.1e  20.8±3.4°  7.4±0.1d  8.2±1.2b  10.8±0.8e  14.7 +0.7°  13.9±0.5d 
Na2SeO4 
4.0ppm  32.4±7.1"'  23.2+3.4°  2.5 +0.1b  6.6±1.2b  4. 9±0. 8b  4.0+0.7b  1.2+0.4' 
* Concentrations in tissues are expressed as mg/g tissue (dry weight). The means of 
selenium concentrations ± standard errors of the means (n=3). Within each column, values 
with different superscripts are significant different at v0.05 or greater. 
Table 2.  Glutathione peroxidase activities in different tissues of guinea pigs fed 
various levels of selenomethionine or one level of selenate 
group*  liver  kidney  brain  testis  spleen  heart  muscle  RBC 
control  64±3  87+4'  52+5  49±1  121+17'  101+9  26±7  135±7a 
Se-Met 
0.5ppm  61±9  83+7'  49+2  46+11  172+9b  103±11  21±7  183±27ab 
1.0ppm  66±1  91±6a  47+5  48+7  165+32b  123±28  21±6  237±27b 
2.0ppm  64+1  46±2b  61+4  47+4  164±13ab  101+18  21+1  147+13a 
4.0ppm  67 ±8  47±5b  50+2  42±4  155±23ab  99±5  27±6  136±39a 
Na2Se04 
z:ip) pm  67±6  41±5b  54+7  40+3  154±2ab  89±2  24+1  158+12a 
* Activities are expressed a n mole NADPH oxidized/min/mg protein or per Hb 
(erythrocytes). The valves are means ± standard errors of the means (n=3).Within each 
column, values with different superscripts are significant different at v0.05 or greater. 179 
GPX fraction  SeP fraction  albumin fraction 
Figure A-2. Selenium content in different fractions of plasma from guinea pigs fed 
control diet or this diet plus 4, 6, or 8µg selenium as selenomethionine per g diet. The 
means ± standard errors of selenium concentrations in plasma were 105 ± 9, 596 ± 
68, 987 ± 250 and 1285 ± 54 ng/ml respectively for animals fed control diet or this 
plus 4, 6 or 8 itg selenium as selenomethionine per g diet.  Bars indicate means ± 
standard errors of the means (n=4). Different superscripts indicate significant 
differences (p < 0.05). 180 
GPX fraction  SeP fraction  albumin fraction 
Figure A-3. Selenium content in different fractions of plasma from guinea pigs fed 4 
pcg selenium as either selenomethionine or selenate per g diet. The means ± standard 
errors of selenium concentrations in plasma were 398 ± 21 and 925 ± 253 ng/ml 
respectively for animals fed either selenate or selenomethionine. Bars indicate means 
± standard errors of the means (n=3). Different superscripts represent significant 
differences (p <0.05). 181 
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Figure A-4. Percent distribution of selenium between different fractions of plasma 
from guinea pigs fed diets with either no selenium addition or additions of 0.5, 1, 2, 
4, 6 or 8 pg selenium as selenomethionine per g diet. Error bars at each point indicate 
standard errors of the means (n=3).  Points with different letters are significantly 
different (p < 0.5). 182 
The ratios of selenium to albumin both in plasma and in the albumin fraction 
itself of the combined data from both experiments are shown in figure A-5. There was 
a slight increase but significant in plasma of these ratios in both fractions up to 2 mg 
selenium per kg diet where a marked increase subsequently occurred with higher 
selenium intakes. The ratios of selenium to albumin in both fractions in plasma from 
pigs fed diets with 4 or more selenium per kg diet were significantly higher than these 
ratios in plasma of pigs fed the diets with lower levels of selenium. 
The selenium content in the plasma fractions from the Chinese women and the 
American male is shown in figure A-6.  Similar to the guinea pig study, selenium 
increased in each of the plasma fractions with increased selenium intakes. The amount 
of selenium in the albumin fractions of the American subject was very similar to that 
for the Chinese living in the high selenium area.  The amount of selenium in the 
selenoprotein P fraction from women living in the adequate areas was similar to that 
in the albumin fraction from women living in the high selenium areas of China, which 
were significantly higher than that in the GPX fraction from women living in any of 
the areas of this country. 
The percentage distributions of selenium between the three fractions in plasma 
from women living in the different areas of China are shown in figure A-7. Except 
for the GPX fraction, the patterns are very similar to that found in the guinea pigs. 
A gradual decline in the percentage of selenium in selenoprotein P occurred with 
increased selenium intake, but the opposite pattern occurred in the albumin fraction 
where there was an increase with increased selenium intake. The percentage of 183 
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Figure A-5. Ratios of selenium to albumin either in plasma or in the albumin fraction 
from guinea pigs fed diets with either no selenium addition or additions of 0.5, 1, 2, 
4, 6 or 8µg selenium as selenomethionine per g diet. Error bars at each point indicate 
standard errors of the means (n=3). Points with different letters are significantly 
different (p < 0.5). 184 
GPX fraction  SeP fraction  albumin fraction 
Figure A-6. Selenium content (ng/ml plasma) in different fractions of plasma from 
Chinese Woman living in low, adequate or high selenium areas, and an American 
subject who took a selenium supplement (800 to 1000 mg Se/day) of selenium enriched 
yeast. The means ± standard errors of selenium concentration in plasma were 33 ± 
8, 102 ± 18 and 393 ± 128 ng/ml respectively for Chinese subjects living in low, 
adequate or high selenium areas of China, and 375 ng/ml for the American subject. 
Bars indicate means ± standard errors of the means (n=6). Different superscripts 
indicate significant differences (p <0.05). 185 
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Figure A-7. Percent distribution of selenium between different fractions of plasma 
from Chinese women living in low, adequate or high selenium areas. Error bars at 
each point indicate standard errors of the means (n=6). The percent distribution of 
selenium was 17.2, 38.2 and 44.6 respective for GPX fraction, selenoprotein P 
fraction and albumin fraction in plasma from the American subject who took high 
selenium supplements. Points with different letters are significantly different (p < 0.5). 186 
selenium in the GPX fraction remained rather constant and no significant difference 
were found in women living in the three areas of China. 
The ratios of selenium to albumin in the plasma and to that in the albumin 
fraction itself showed similar patterns to that for the guinea pigs (figure A-8). These 
ratios increased  with each  increase of selenium  intakes.  This  ratio was not 
different in the albumin fraction from women living in the adequate area versus those 
living in the low selenium area, but was significantly higher in those women living in 
the high selenium areas.  Although this ratio was higher in the whole plasma from 
women living in the adequate area, it was not significantly different from those living 
in deficient area but this ratio was higher in women living in the high selenium area 
of China. 
DISCUSSION 
The purpose of these experiments were to obtain information on how to 
determine impending selenium toxicity before physiological signs occur.  It was 
hypothesized that the ratios of selenium to albumin in either the plasma or the albumin 
fraction itself could be used to assess this impending problem. These ratios increased 
in plasma of both the guinea pigs (figure A-5) and humans (figure A-8) with increased 
selenium intakes, but a plateau in these ratios was not reached in either case. There 
were no signs of selenium toxicity in either the guinea pigs or human subjects. Thus, 
presumably higher ratios of selenium to albumin would be reached with selenium 187 
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Figure A-8. Ratios of selenium to albumin either in plasma or in albumin fractions 
from Chinese women living in low, adequate or high selenium areas. Error bars at 
each point indicate standard errors of the means (n =6). Ratios of selenium to albumin 
in plasma and in albumin fraction were 11.9 and 5.5 in the American subject who took 
high selenium supplement. Points with different letters are significantly different (p < 
0.5). 188 
toxicity. One reason for using guinea pigs was because rats were shown not to be 
suitable for this type of evaluation (Whanger et al, 1994b).  However, the actual ratios 
of selenium to albumin in guinea pigs are not applicable to humans because the 
albumin content in plasma of guinea pigs (1.05 ± 0.11 g/dL) are significantly lower 
than in humans (3.62 ± 0.78 g/dL) .  This is the reason for much higher ratios in 
plasma from guinea pigs (figure A-5) than plasma from humans (figure A-8). These 
ratios in guinea pigs fed the diet with 1 mg selenium per kg diet was similar to those 
for women living in the high selenium area of China. Therefore, even though the 
trends are similar in humans and guinea pigs the use of actual ratios for application to 
humans appear highly questionable. 
Another problem is that these ratios would not be applicable for selenium in 
forms other than Semet. The basis for this evaluation would be the accumulation of 
selenium in the albumin fractions which does not occur to a significant extent when 
given selenium as selenate (figure A-3). The differences in selenium metabolism 
between organic and inorganic selenium have been noted in other investigations 
(Combs and Combs, 1986; Whanger and Butler, 1988). 
Even though no signs of selenium toxicity occurred in women living in the high 
selenium areas of China if the assumption is made they are at subtoxic levels (Yang et 
al, 1989 a, b) then ratios of selenium to albumin greater than 9.0 in plasma or 3.5 in 
the albumin fraction itself should be taken as biological indications of possible 
impending selenium toxicity. Previous work indicated that the main form of selenium 
intake was Semet of the Chinese living in the high areas (Beilstein et al, 1991). This 189 
is probably the main reason the distribution of selenium in the three fractions of the 
American subject was very similar to that for the Chinese living in this high selenium 
area. The predominant form of selenium in selenium enriched yeast has been shown 
to be Semet (Beilstein and Whanger, 1986), but data has been obtained that this is not 
true for all selenium enriched sources of yeast (Power,1994). 
Chinese formerly living in the extremely high areas of that country are no 
longer residing there (Yang et al, 1983), and thus their blood are not now available for 
further assessment of toxicity. The availability of blood from these subjects could have 
provided some indication of the selenium intake in humans required to provide a 
plateau in the ratio of selenium to albumin. Extremely high levels of selenium were 
found in their blood, hair, urine (Yang et al, 1983) and fingernails (Whanger et al, 
1996).  Significant correlations have been found between daily selenium intake and 
selenium content of whole blood, breast milk and 24 hour urine (Yang et al, 1989a). 
Highly significant correlations were also found between urinary selenium and plasma 
selenium, whole blood selenium and hair selenium, fingernail selenium and toenail 
selenium, hair selenium and fingernail selenium, hair selenium and toenail selenium, 
whole blood selenium and toenail selenium, and between whole blood selenium and 
fingernail selenium (Yang et al, 1989 a, b). 
Increases of the selenium concentration in guinea pig tissues (table A-1) without 
a corresponding increase of GPX activity (table A-2) is consistent with data with rats 
(Whanger and Butler, 1988). The lack of increase of GPX activity in most tissues in 
comparison to those from control animals (table A-2) indicates that the amount of 190 
selenium in the basal diet was sufficient to meet dietary needs (Lei et al, 1995). 
Research work indicates that once required amounts of selenium are given, GPX 
activity reaches a plateau with higher intakes. It is interesting that in such tissues as 
kidney, spleen and erythrocytes the activity of this selenoenzyme decreased with 
dietary levels of selenium of 2.0 mg per kg diet and above, possibly reflecting 
oxidative stress imposed upon the animal with excessive intakes of selenium. 
The present results indicate that the Chinese living in different areas of that 
country can be advantageously used to study the effects of intakes of various levels of 
this element.  The maximum safe intake of selenium for humans has been assessed. 
The low adverse effect level of dietary selenium was calculated to range between 1540 
to 1600 gg (Yang and Zhou, 1994). However, some effects were noted in individuals 
with a daily intake of 900 gg. The maximum safe dietary selenium intake was 
calculated to be about 800 gg per day, but there were some individuals where an 
amount of 600 gg per day was the maximum safe intake. Using a safety margin, the 
maximum safe dietary selenium intake was suggested as 400 gg per day. Thus, with 
this type of variations between individuals, a better biomarker for selenium toxicity is 
warranted. 
The use of the dual column method to separate the major selenium fractions in 
the plasma has some limitations, particularly with Semet as the selenium source. 
Increases of selenium in the GPX fraction were found with elevated dietary intakes of 
this element (figures A-1 and A-2), but this is due to nonspecific incorporation of 
selenium from Semet into proteins (Deagen et al, 1993). From 12 to 15% of the 191 
selenium in plasma is associated with GPX (Avissar et al, 1989) and values above this 
as shown in figures 1 and 2 represent non specific incorporation of selenium into 
general proteins. This is not a problem when inorganic selenium is used because of 
specific incorporation of selenium from this source into selenoproteins (Deagen et al, 
1993). The dual column method, however, is suitable for determining the selenium 
in selenoprotein P and albumin. Antibody methods have been developed to determine 
the selenoprotein P levels in plasma of both rats (Read et al, 1990) and humans (Hill 
et al, 1996). While the antibody procedure is a much more specific method for this 
measurement, it has its limitation because of animal species specificity. Because of 
this specificity, antibodies need to be raised against selenoprotein P from the animal 
of interest to make these measurements. While antibodies have been raised against 
plasma GPX (Avissar et al, 1989) this is not a very practical method for routine 
determinations of selenium in the GPX fraction of plasma. Neither of these methods 
can be used to accurately assess the selenium content in albumin.  Thus, the dual 
column procedure used in the present work offer a method for estimation of selenium 
in all major plasma fractions from any species of animal needed to be investigated. 
In summary, while no firm conclusions were reached on the actual ratio of 
selenium to albumin as indicative of impending selenium toxicity, the data suggest that 
this method holds merit for this assessment.  It is suggested that ratios of selenium to 
albumin above 9.0 in plasma or above 3.5 in the albumin fraction be taken as 
indication of excessive intake of selenium. Unfortunately this method applies only to 192 
Semet and another method needs to be develop for assessing elevated intakes of other 
forms of selenium in humans. 
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APPENDIX B 
PRELIMINARY WORK ON SELENOPROTEIN W IN PRIMATE 
Selenoprotein W is a low molecular weight protein containing selenium in the 
form of selenocysteine. Because no enzymatic function for this protein is known, the only 
analytical method available now is an immunological assay. Ployclonal antibodies raised 
against rat selenoprotein W peptide are sufficient to detect selenoprotein W by Western 
blots in tissues of rats, mice, guinea pigs, cattle and sheep species. The occurrence and 
distribution of selenoprotein W in primate tissues are of particular interest because 
humans, like sheep, suffer from selenium deficiency myopathies. Due to the lack of the 
source of human tissues, rhesus monkey could be a good model for humans. Deduced 
amino acid sequences of selenoprotein W indicate 100% identical between human and 
rhesus monkey species. 
Generation and purification of polyclonal antibody 
Two peptides based on the amino acid residues 13-31 of rat and human 
selenoprotein W sequences were synthesized respectively by Central Service Laboratory 
of Gene Research and Biotechnology at Oregon State University. These peptides were 
synthesized with cysteine replacing selenocysteine at the N-terminal ends for conjugation 
to Keyhole limpet hemocyanin (KLH). The KLH-conjugated synthetic peptides were 
used for immunization of rabbits respectively to generate polyclonal antibodies. The 
polyclonal antibodies were purified by peptide-coupled Sulfoline affinity columns and 196 
used in Western blots. 
Expression and purification of mutant selenoprotein W from bacteria 
A site-specific mutation was introduced into a cloned gene (human or rat 
selenoprotein W) by amplifying the gene using PCR with specifically designed mutagenic 
oligonucleotide primers that contained the desired mutation (changed selenocysteine 
codon TGA to cysteine codon TGT) in the forward primer and six histidine codons in the 
reverse primer. The restriction enzyme sites (Ncol and BamH1) were also introduced into 
both end sites by PCR for ease of cloning. PCR products and pTrc 99a vector were 
digested with Ncol & BamH1, ligated and transformed into the TG1 host strain. The 
transformers were screened by correct insertion size of the cloning fragment using 
restriction analysis. The correct cloning  junctions and desired substitutions were 
confirmed by sequencing. The recombinant plasmid was then transferred into BL21DE 
pLyss host strain. The expression culture was induced with 0.1 mM IPTG and the 
expressed target protein was purified by a Ni-NTA agarose column and a reverse phase 
HPLC column. 
Western blot analysis 
Tissues from rhesus monkeys were obtained from the Primate Research Center 
in Beaverton, OR. Prepared Western blot of a panel of human tissues was purchased from 
Clontech. For comparison, skeletal muscle tissues from rat, sheep and guinea pigs fed 
diets with 1, 3 and 4 lig selenium per g and prepared for Western blot analysis. 
As shown in figure B-1, a signal hybridized with antibodies against rat 197 
selenoprotein W peptide was located between molecular masses of 6 KDa and 14 KDa 
for muscle samples from rat, guinea pig and sheep, while it was located between 
molecular masses of 21 KDa and 30 KDa for muscle and tongue samples from monkeys 
and for muscle and heart samples from a human multiple tissue Western blot. There were 
no detectable bands in the other tissues examined. However, these results suggested that 
the apparent molecular weight of the proteins in primates were about 2.5 times larger than 
the actual molecular weight of selenoprotein W in rat. 
As shown in figure B-2, Western blots indicated the antibodies raised against 
either human or rat selenoprotein W peptides recognized both the mutant rat and human 
proteins with estimated molecular weights of 10 KDa. However, when 100 lig total 
proteins of monkey muscle cytosol were loaded, the antibodies against rat peptide gave 
a band about 25 KDa, and the antibodies against human peptide failed to detect any 
proteins. 
When the antibodies to either human or rat peptides were used respectively as 
primary antibody in the same preparation of 200 lig total proteins for each monkey tissue 
in Western blots, it was found that antibodies against human peptide can recognized the 
selenoprotein W in monkey tissues with very low affinity (figure B-3A). The mutant 
human selenoprotein W expressed by bacteria showed a distinct band, muscle and brain 
tissues showed a week signal with estimated molecular weight about 10 KDa, while other 
tissues were undetectable. However, antibodies raised against rat peptide hybridized to 
a protein in skeletal muscle and tongue tissues had an apparent molecular weight of 25 
KDa (figure B-3B). Because the cDNA sequence indicates that the primate selenoprotein 198 
W is the same size as the rodent protein, the higher molecular weight protein found in 
primate tissues is not selenoprotein W and that recognized by the antibodies is another 
protein. 
These results indicate that antibodies raised against rat selenoprotein W peptide 
are sufficient for detecting selenoprotein W in tissues of species such as rat, sheep, and 
guinea pigs, but not for selenoprotein W in primate tissues. The large molecular weight 
signals detected in primate tissues could be a specific muscle protein containing some 
regions with highly similarity to rat selenoprotein W peptide sequence. Furthermore, 
Western blot analysis indicated that antibodies raised against human selenoprotein W 
peptide could recognize selenoprotein W but with very low affinity. Because of this low 
affinity, this polyclonal antibodies failed to recognize selenoprotein W in human tissues 
(data not shown) and most of monkey tissues. Therefore, functional antibodies were 
needed for detecting selenoprotein W in primate tissues. As described in chapter 3, a 
mutant human selenoprotein W (selenocysteine was substituted by cysteine) was 
produced in a bacteria expression system. The antibodies raised against this mutant 
protein were demonstrated to function well in Western blots of primate tissues. 199 
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Figure B-1. Western blot analysis of selenoprotein W in various species using polyclonal 
antibodies raised against a synthetic peptide derived from rat muscle selenoprotein W. A. 
200 ug of total cytosol protein samples from muscles were separated by a 7.5-15% SDS­
polyacrylamide gradient gel and transferred onto nitrocellulose membrane. Molecular 
markers were labeled at the left side. Lanes 1-3, 200 lig cytosol protein samples from 
muscles of rat, guinea pig, and sheep respectively. Lanes 4-9, 200 pg cytosol protein 
samples from muscle, tongue, liver, brain, spleen and kidney of monkey. B. Human 
multiple tissue Western blot purchased from Clontech. Molecular markers were labeled 
at the left side. 75 pg of total protein from each tissue was located in each well. Lanes 
1-6 are brain, heart, kidney, lung, skeletal muscle and liver samples. 200 
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Figure B-2. Western blot of the expressed protein by E.coli and monkey muscle using 
antibodies against either rat peptide (A) or human peptide (B). Lanes 1, 10 ng pure 
selenoprotein W from rat skeletal muscle. Lane 2, 100 .xg total protein extracts from 
monkey muscle. Lane 3, 10 ng pure mutated human selenoprotein W expressed by 
bacteria. Lane 4, 10 ng pure mutated human selenoprotein W expressed by bacteria. The 
positions of molecular weight markers were shown at the left side. 201 
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Figure B-3. Western blot analysis of selenoprotein W in monkey tissues. A. Using the 
polyclonal antibodies against human peptide. Lanes 1-6, 200 lig of cytosol protein 
samples from muscle, tongue, liver, brain, spleen, kidney, and heart respectively. Lane 
8, 10 ng of pure mutated human selenoprotein W expressed by bacteria. The positions 
of molecular weight markers were shown at the left side.  B. Using the polyclonal 
antibodies against human peptide. Lanes 1-6, 200 jig of cytosol protein samples from 
muscle, tongue, liver, brain, spleen, kidney, heart respectively. Lane 8, 10 ng of pure 
mutated rat selenoprotein W expressed by bacteria. 202 
APPENDIX C 
CALCIUM BINDING ASSAY 
Calcium binding proteins play important roles in the regulation of various kinds 
of cell activities.  It is speculated that selenoprotein W could be a regulatory protein 
because of its presence at very low concentration in tissues. Examination of selenoprotein 
W amino acid sequences  revealed a region, amino acids 60-71, which is highly 
homologous with the calcium binding domain of calmodulin. Coincidently, selenoprotein 
W purified from either rat or monkey skeletal muscle contained an unidentified small 
moiety with a molecular weight similar to calcium. The present assay was preformed to 
examine whether selenoprotein W can bind calcium. 
Preparation of proteins and labeling of the membrane with 'Ca 
Selenoprotein W was purified from rat or sheep skeletal muscle. Mutant human 
or rat selenoprotein W (Secys was replaced by Cys) was expressed by E. coli and purified 
by a Ni-NTA agarose column. Protein concentration was determined by Lowry method 
using bovine serum albumin as standard. Pure calpain (80 KDa subunit) was purchased 
from Sigma. 
45CaC12 was purchased from New England Nuclear Corporation. Protein was 
dissolved in a SDS sample buffer, followed by heating at 100 °C for 5 min prior to loading 
on 12% SDS-polyacrylamide gel. One sample of each mutant selenoprotein W was 
incubated with 10 mM dithiothreitol at 50°C for 1 hour before dissolving in a SDS sample 
buffer. After electrophoresis, the gel was placed on the nitrocellulose membrane. Transfer 203 
was performed at a constant current of 100 mA for 2 hours at 4 °C. Alternatively, the 
protein without denaturing conditions was loaded directly on the nitrocellulose membrane 
in slot blot apparatus. The membrane was soaked in a solution containing 60 mM KCI, 
5 mM MgCl2, and 10 mM imidazole-HC1 (pH 6.8) and the buffer was exchanged three 
times in an hour to wash away the electrode buffer. The membrane was incubated in the 
same buffer containing 1 mCi/liter 'Ca for 10 min, rinsed with distilled water for 5 min 
and dried at room temperature for 3 hours. Autoradiographies of the "Ca labeled 
proteins on the nitrocellulose membrane were obtained by exposure of the dried 
membrane to X-ray film for 24 hours. 
Immunological assay of selenoprotein W 
After the development of films, the membrane was blocked by incubation with 5% 
non fat milk in TTBS (50 mM Tris -HCI, pH 7.5, o.5 M NaCI, 0.05% Tween-20) for 1 
hour. The membrane was hybridized with primary antibody against rat selenoprotein W 
peptide for 2 hours.  After three washes with TTBS, secondary antibody (HRP­
conjugated goat anti rabbit IgG, diluted 1:2000 in TTBS containing 1% non fat skim 
milk) was added and incubated for 1 hour. Following washing with TTBS for four times, 
specific selenoprotein W signal on the membrane was detected by the ECL detection 
system. 
Mass spectrometry assay to characterize mutant selenoprotein W 
A custom-built time-of-flight mass spectrometer equipped with a frequency tripled 
(355 nm) Na:YAG laser of pulsed matrix-assisted laser desorption/ionization (MALDI) 204 
mass spectrometry was used to determine the molecular weight of bacterial expressed 
mutant selenoprotein W which was purified by Ni-NTA (figure C-1). The mass of 10611 
Da was consistent with theoretical molecular weight calculated based on the mutant rat 
selenoprotein W cDNA (including 6 histidine tail). The mass was shifted to 11300 after 
treated sample with final concentration of 10 mM dithiothreitol at 50° C for 1 hr (figure 
C-1B).  It was assumed that this removed glutathione, which was similar to native 
selenoprotein W purified from rat and monkey skeletal muscle. Incubation with calcium 
did not change the molecular mass of original mutant rat selenoprotein W but increased 
34 and 185 masses of mutant rat selenoprotein W after treated sample with dithiothreitol 
(figure C-2). The identities of increased masses are not clear. 
Comparison 'Ca autoradiography with immunoreactive signals 
Autoradiography of the membrane revealed the presence of calcium binding 
protein as a radioactive band in the rat selenoprotein W preparation whose position was 
located between 6 KDa and 14 KDa (figure C-3A). No other radioactive bands were 
identified in the mutant selenoprotein W preparation. However, immunological analysis 
indicated the presence of selenoprotein W in the rat selenoprotein W preparation as a 
single band and in the mutant selenoprotein W preparations with or without dithiothreitol 
treatment as multiple bands due to overloaded (figure C-3B). The radioactive band did 
not hybridize with rat selenoprotein W antibody.  It was assumed that this radioactive 
band could be a calcium binding protein which co-purified with selenoprotein W from rat 
skeletal muscle. When protein without denaturing was added on the membrane, 
autoradiography of the membrane did not show any 'Ca labeled bands for either sheep 205 
selenoprotein W or mutant selenoprotein W, but, calpain, a calcium dependent proteinase, 
showed a weak labeled band (figure C-4A).  Immunological analysis indicated the 
presence of selenoprotein W in both sheep selenoprotein W or mutant selenoprotein W 
preparations (figure C-4B). 
The present results indicated that selenoprotein W did not possess the ability to 
bind calcium, based on the present procedures.  It should be pointed out that not all 
calcium binding protein can be identified by the method used in this experiment, because 
some calcium binding proteins might lose their calcium binding ability with the denaturing 
conditions of SDS gel. Although an alternative procedure was used where the protein 
was added to the membrane without denaturing condition on the slot blot apparatus, no 
information was obtained on either the state of proteins absorbed or their calcium binding 
capacity to the nitrocellulose membrane.  Further studies are needed  to determine 
whether calcium is involved in mediating selenoprotein W functions. 206 
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Figure C-1. MALDI mass spectrum of mutant rat selenoprotein W before (A) and after 
(B) incubation with dithiothreitol at 50°C for 60 min. The mass peak has shifted from miz 
= 10611 to 10300. Singly, double and triply charged ions corresponding to the mutant rat 
selenoprotein W are indicated as graphics. 207 
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Figure C-2. MALDI mass spectrum of mutant rat selenoprotein W incubation original 
form (A) and the form after treated with dithiothreitol at 50°C for 60 min (B) with 
calcium respectively. The mass did not change in (A), but increased 44 and 185 Daltons 
in (B). 208 
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Figure C-3. Identification of calcium binding proteins (A) or selenoprotein W (B) on 
nitrocellulose membrane after SDS electrophoresis. Lane 1,  rat skeletal muscle 
selenoprotein W preparation. Lane 2, mutated rat selenoprotein W preparation treated 
with DTT. Lanes 3-4, 1 or 0.1 j.ig of mutated rat selenoprotein W preparation. Lane 5, 
mutated human selenoprotein W preparation treated with DTT. Lanes 6-7, 1 or 0.1 lig 
of mutated human selenoprotein W preparation. The positions  of molecular weight 
markers were shown at the left side. 209 
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Figure C-4. Identification of calcium binding proteins (A) or selenoprotein W (B) on 
nitrocellulose membrane of slot blot. R, mutated rat selenoprotein W preparation. H, 
mutated human selenoprotein W preparation. S, sheep selenoprotein W preparation from 
skeletal muscle. C, pure calpain obtained from Sigma. 